Processing 00000000.tx.1: -Amyloid-(1-42) Impairs Activity-dependent cAMP-response Element-binding Protein Signaling in Neurons at Concentrations in Which Cell Survival Is Not Compromised* Liqi Tong, Phillip L. 

Phrase: "-Amyloid-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Impairs"

Phrase: "Activity-dependent cAMP-response Element-binding Protein Signaling in Neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1155589:cAMP signaling [Molecular Function]
   757   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0037083:Signaling [Cell Function]
   739   C3537152:signaling [Biologic Function]

Phrase: "at Concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in Which Cell Survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "Is"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Compromised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2945640:compromise [Finding]

Phrase: "* Liqi Tong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0183964:Tong [Medical Device]

Phrase: "Phillip L."
Processing 00000000.tx.2: Thornton, Robert Balazs, and Carl W. 

Phrase: "Thornton,"

Phrase: "Robert Balazs,"

Phrase: "and"

Phrase: "Carl W."
Processing 00000000.tx.3: Cotman From the University of California, Irvine Institute for Brain Aging and Dementia, Irvine, California 92697-4540 Received for publication, November 20,2000, and in revised form, February 19,2001  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Cognitive impairment is a major feature of Alzheimer's disease and is accompanied by -amyloid (A) deposition. 

Phrase: "Cotman From the University of California,"

Phrase: "Irvine Institute for Brain Aging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "Irvine,"

Phrase: "California 92697-4540"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006754:California [Geographic Area]
   827   C3146274:California [Plant]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "November 20,"

Phrase: "2000,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "February 19,"

Phrase: "2001  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cognitive impairment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   861   C0684336:Impairment [Pathologic Function]

Phrase: "is"

Phrase: "a major feature of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "accompanied by -amyloid (A) deposition."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   833   C1705760:Amyloid Deposition [Finding]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0333562:Deposition [Functional Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.4: Transgenic animal models that overexpress A exhibit learning and memory impairments, but neuronal degeneration is not a consistent characteristic. 

Phrase: "Transgenic animal models"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0003069:Transgenic Animal [Animal]
   901   C0599779:Models, Animal [Animal]
   896   C1519606:Transgenic Model [Experimental Model of Disease]
   827   C0003062:Animal [Animal]
   827   C3161035:Models [Intellectual Product]

Phrase: "that"

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "A exhibit learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013621:learning [Educational Activity]
   827   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory impairments,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0233794:Memory impairment [Mental or Behavioral Dysfunction]
   983   C1963167:Memory impairment [Finding]
   861   C0684336:Impairments [Pathologic Function]
   861   C2598156:Impairments [Clinical Attribute]

Phrase: "but"

Phrase: "neuronal degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a consistent characteristic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521970:Characteristic [Qualitative Concept]
Processing 00000000.tx.5: We report that levels of A-(1-42), which do not compromise the survival of cortical neurons, may indeed interfere with functions critical for neuronal plasticity. 

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that levels of A-"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "compromise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "the survival of cortical neurons,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1819944:neuron survival [Cell Function]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "may"

Phrase: "indeed"

Phrase: "interfere with functions"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0521102:Interfere [Qualitative Concept]
   790   C0542341:Functions [Functional Concept]
   756 E C0031843:function [Physiologic Function]
   756 E C0700205:FUNCTION [Classification]
   756 E C1705273:Function [Intellectual Product]
   706 E C0205245:Functional [Functional Concept]
   706 E C2700217:Functional [Conceptual Entity]

Phrase: "critical for neuronal plasticity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]
Processing 00000000.tx.6: Pretreatment with A-(1-42), at sublethal concentrations, resulted in a suppression of cAMP-response element-binding protein (CREB) phosphorylation, induced by exposure to either 30mM KCl or 10M N-methyl-D-aspartate. 

Phrase: "Pretreatment with A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "at sublethal concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "resulted in a suppression of cAMP-response element-binding protein (CREB) phosphorylation,"
Meta Candidates (Total=29; Excluded=1; Pruned=0; Remaining=28)
   820   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C3158668:cAMP response element binding [Genetic Function]
   775   C1511573:cAMP Response Element [Gene or Genome]
   756   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   754 E C0033618:Protein Binding [Molecular Function]
   754   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   754   C1148918:cAMP binding [Molecular Function]
   738   C0013879:Element [Element, Ion, or Isotope]
   738   C0031715:Phosphorylation [Molecular Function]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   738   C0221103:Suppression [Pathologic Function]
   738   C0243122:binding [Functional Concept]
   738   C0301625:Suppression [Organism Function]
   738   C0439181:% suppression [Quantitative Concept]
   738   C0728721:suppression [Mental Process]
   738   C0871261:Response [Organism Attribute]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1704632:Response [Finding]
   738   C1705248:Element [Conceptual Entity]
   738   C1706817:Response [Intellectual Product]
   738   C2911692:Response [Mental Process]
   704   C1274040:Result [Functional Concept]
   704   C1546471:Result [Idea or Concept]
   704   C2825142:Result [Finding]

Phrase: "induced by exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205263:Induced [Functional Concept]
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]

Phrase: "to either 30mM KCl"

Phrase: "or"

Phrase: "10M N-methyl-"

Phrase: "D-"

Phrase: "aspartate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.7: The effects of A-(1-42) seem to involve mechanisms unrelated to degenerative changes, since A-(25-35), a toxic fragment of A, at sublethal concentrations did not interfere with activity-dependent CREB phosphorylation. 

Phrase: "The effects of A-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "involve"

Phrase: "mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "unrelated to degenerative changes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0445356:Unrelated [Finding]
   770   C1704623:Unrelated [Qualitative Concept]

Phrase: "since"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: ","

Phrase: "a toxic fragment of A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332255:fragment [Functional Concept]
   760   C1708096:Fragment [Qualitative Concept]

Phrase: "at sublethal concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with activity-dependent CREB phosphorylation."
Meta Candidates (Total=31; Excluded=1; Pruned=0; Remaining=30)
   833   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C3158668:cAMP response element binding [Genetic Function]
   782   C1511573:cAMP Response Element [Gene or Genome]
   760   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   757 E C0033618:Protein Binding [Molecular Function]
   757   C1148918:cAMP binding [Molecular Function]
   757   C1537044:protein activity [Molecular Function]
   757   C2266866:Binding Activity [Molecular Function]
   739   C0013879:Element [Element, Ion, or Isotope]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   739   C0205177:Activity [Functional Concept]
   739   C0243122:binding [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C0521102:Interfere [Qualitative Concept]
   739   C0851827:Dependent [Qualitative Concept]
   739   C0871261:Response [Organism Attribute]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1561536:*Activity [Idea or Concept]
   739   C1701901:Dependent [Qualitative Concept]
   739   C1704632:Response [Finding]
   739   C1705248:Element [Conceptual Entity]
   739   C1706817:Response [Intellectual Product]
   739   C2911692:Response [Mental Process]
   739   C3244310:dependent [Functional Concept]
Processing 00000000.tx.8: Furthermore, caspase inhibitors failed to counteract the A-(1-42)-evoked suppression of CREB activation. 

Phrase: "Furthermore,"

Phrase: "caspase inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1516312:Caspase Inhibitors [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "counteract"

Phrase: "the A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "evoked suppression of CREB activation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0221103:Suppression [Pathologic Function]
   742   C0301625:Suppression [Organism Function]
   742   C0439181:% suppression [Quantitative Concept]
   742   C0728721:suppression [Mental Process]
Processing 00000000.tx.9: A-(1-42) also interfered with events downstream of activated CREB. 

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "also"

Phrase: "interfered with events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441471:Events [Event]
   790   C0521102:Interfered [Qualitative Concept]
   790   C3541888:Events [Classification]

Phrase: "downstream of activated CREB."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
Processing 00000000.tx.10: The A-(1-42) treatment suppressed the activation of the cAMP response element-containing brain-derived neurotrophic factor (BDNF) exon III promoter and the expression of BDNF exon IIII mRNA induced by neuronal depolarization. 

Phrase: "The A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "the activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of the cAMP response element-containing brain-derived neurotrophic factor (BDNF) exon III promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the expression of BDNF exon IIII mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1515670:mRNA Expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "induced by neuronal depolarization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induced [Functional Concept]
   770   C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.11: In view of the critical role of CREB and BDNF in neuronal plasticity, including learning and memory, the observations indicate a novel pathway through which A may interfere with neuronal functions and contribute to cognitive deficit in Alzheimer's disease before the stage of massive neuronal degeneration.  

Phrase: "In view of the critical role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "of CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "BDNF in neuronal plasticity,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   853   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   816   C1826397:NEURON-DERIVED NEUROTROPHIC FACTOR [Gene or Genome]
   816   C3472710:neuron-derived neurotrophic factor [Gene or Genome]
   778   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1441547:Derived [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
   748   C3245521:derived [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "the observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicate"

Phrase: "a novel pathway through which A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "may"

Phrase: "interfere with neuronal functions"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0521102:Interfere [Qualitative Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C0542341:Functions [Functional Concept]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "contribute to cognitive deficit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0679466:cognitive deficit [Mental or Behavioral Dysfunction]
   770   C0162429:Deficit, NOS [Disease or Syndrome]
   770   C1516691:Cognitive [Functional Concept]
   770   C1880177:Contribute [Activity]
   770   C2987487:Deficit [Qualitative Concept]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "before the stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "of massive neuronal degeneration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   865   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   827   C0011164:Degeneration [Pathologic Function]
   827   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Alzheimer's disease (AD)1 is identified by a progressive decline in cognitive functions and is characterized by neuropathologies including senile plaques comprising -amyloid (A) peptide, neurofibrillary tangles, and ultimately neuron loss. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)1"

Phrase: "is"

Phrase: "identified by a progressive decline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205329:Progressive [Functional Concept]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "in cognitive functions"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
  1000   C0392335:Cognitive functions [Mental Process]
   861   C0542341:Functions [Functional Concept]
   861   C1516691:Cognitive [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "is"

Phrase: "characterized by neuropathologies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1880022:Characterized [Activity]
   756   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   756   C1540677:neuropathology [Pathologic Function]
   756   C1555824:Neuropathology [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "comprising -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2700400:Comprise [Activity]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A) peptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "neurofibrillary tangles,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "ultimately neuron loss."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0598940:neuron loss [Finding]
   865 E C1850496:Neuronal loss [Finding]
   827   C1517945:Loss [Quantitative Concept]
Processing 00000000.tx.13: Mutations in the A precursor protein (APP) and in the presenilin (PS1 and -2) genes have been identified, which co-segregate with familial Alzheimer's disease (FAD) (1, 2). 

Phrase: "Mutations in the A precursor protein"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(APP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "and in the presenilin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   770   C1515981:And [Idea or Concept]

Phrase: "(PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and -"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "which"

Phrase: "co-segregate with familial Alzheimer's disease (FAD)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   783   C0277558:Familial disease [Disease or Syndrome]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0015576:familial [Family Group]
   753   C0241888:Familial [Functional Concept]
   748 E C0344339:disease family [Finding]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: Overexpression of the mutated genes in cells and in transgenic animals has been shown to mimic some of the features of AD, including increased accumulation of A (1, 3-5). 

Phrase: "Overexpression of the mutated genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and in transgenic animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0003069:Animals, Transgenic [Animal]
           Transgenic
   770   C0003062:Animals [Animal]
   770   C1515981:And [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mimic"

Phrase: "some of the features of AD,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205392:Some [Quantitative Concept]
   753   C3540770:Some [Intellectual Product]
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "increased accumulation of A"

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3-5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442758:3 5 [Quantitative Concept]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: Most significantly, transgenic mice also show impairments in neuronal function (5) and develop deficits in learning and memory (4), although neuron loss is not a consistent feature of the phenotype (4-7). 

Phrase: "Most significantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "transgenic mice also"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "impairments in neuronal function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0684336:Impairments [Pathologic Function]
   770   C2598156:Impairments [Clinical Attribute]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "develop"

Phrase: "deficits in learning"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C2987487:deficits [Qualitative Concept]
   756 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "and"

Phrase: "memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "(4"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "neuron loss"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0598940:neuron loss [Finding]
   964 E C1850496:Neuronal loss [Finding]
   861   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a consistent feature of the phenotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "(4-7"

Phrase: ")."
Processing 00000000.tx.16: Although it is known that A is neurotoxic in vivo and in vitro (8), there are indications that cognitive impairment may precede both high levels of A accumulation and pronounced neuronal degeneration in the brain (5, 9-11). 

Phrase: "Although"

Phrase: "it"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "neurotoxic in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "are"

Phrase: "indications"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0392360:Indications [Idea or Concept]
   966 E C3146298:Indication [Functional Concept]

Phrase: "that cognitive impairment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   861   C0684336:Impairment [Pathologic Function]

Phrase: "may"

Phrase: "precede"

Phrase: "both high levels of A accumulation"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "pronounced neuronal degeneration in the brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   753   C0011164:Degeneration [Pathologic Function]
   753   C1880269:Degeneration [Functional Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "9-11"

Phrase: ")."
Processing 00000000.tx.17: Because of the protractive and progressive nature of the disease, A may be present in the brain at sublethal concentrations for extended periods. 

Phrase: "Because of the protractive"

Phrase: "and"

Phrase: "progressive nature of the disease,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0449786:Nature of disease [Qualitative Concept]
   760   C0349590:Nature [Idea or Concept]
   760   C1262865:Nature [Functional Concept]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "present in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "at sublethal concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "for extended periods."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.18: Although at these levels A does not compromise neuron survival, it may affect critical signal transduction processes that mediate plastic neuronal changes, including those involved in learning and memory. 

Phrase: "Although at these levels A"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0441889:Levels [Qualitative Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "compromise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "neuron survival,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1819944:neuron survival [Cell Function]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "it"

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "critical signal transduction processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1184743:Process [Body Part, Organ, or Organ Component]
   779   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "plastic neuronal changes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "those"

Phrase: "involved in learning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013621:learning [Educational Activity]
   790   C0023185:Learning [Mental Process]
   790   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "memory."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]
Processing 00000000.tx.19: The transcription factor CREB, which regulates expression of cAMP response element (CRE)-containing genes, plays an essential role in learning and memory processes in a variety of species ranging from Drosophila to mammals (12-15). 

Phrase: "The transcription factor CREB,"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   913   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1149367:transcription factor binding [Genetic Function]
   877   C3158668:cAMP response element binding [Genetic Function]
   845   C1148918:cAMP binding [Molecular Function]
   845   C1511573:cAMP Response Element [Gene or Genome]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0013879:Element [Element, Ion, or Isotope]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   795   C0243122:binding [Functional Concept]
   795   C0871261:Response [Organism Attribute]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1704632:Response [Finding]
   795   C1705248:Element [Conceptual Entity]
   795   C1706817:Response [Intellectual Product]
   795   C2911692:Response [Mental Process]

Phrase: "which"

Phrase: "regulates"

Phrase: "expression of cAMP response element (CRE)-containing genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0017262:Gene Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an essential role in learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "memory processes in a variety of species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0679052:memory process [Mental Process]
   714   C1184743:Process [Body Part, Organ, or Organ Component]
   714   C1522240:Process [Phenomenon or Process]

Phrase: "ranging from Drosophila"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0013138:Drosophila [Eukaryote]
   790   C1028876:Drosophila [Fungus]
   790   C1504613:Drosophila [Eukaryote]
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to mammals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024660:Mammals [Mammal]

Phrase: "(12-15"

Phrase: ")."
Processing 00000000.tx.20: Phosphorylation at Ser-133 is critical for the transcriptional activity of CREB (16-18). 

Phrase: "Phosphorylation at Ser-133"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "critical for the transcriptional activity of CREB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1511545:Critical [Qualitative Concept]

Phrase: "(16-18"

Phrase: ")."
Processing 00000000.tx.21: Neuronal activity-dependent phosphorylation of Ser-133 of CREB has been well documented, and in cultured neurons, both NMDA receptor activation and membrane depolarization can lead to the activation of CREB (17-19). 

Phrase: "Neuronal activity-dependent phosphorylation of Ser-133"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "of CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "well documented,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C1301725:Documented [Health Care Activity]
   861   C1609436:documented [Idea or Concept]
   861   C3146287:Well [Manufactured Object]
   827 E C1301746:document [Intellectual Product]
   827 E C1547673:Document [Intellectual Product]

Phrase: "and in cultured neurons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027882:Neurons [Cell]
   770   C1515981:And [Idea or Concept]

Phrase: "both NMDA receptor activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1514758:Receptor Activation [Cell Function]
   827   C1879547:Activation [Activity]
   734   C0080093:NMDA receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1152805:NMDA receptor [Molecular Function]

Phrase: "and"

Phrase: "membrane depolarization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1816453:membrane depolarization [Cell Function]

Phrase: "can"

Phrase: "lead to the activation of CREB"
Meta Candidates (Total=28; Excluded=1; Pruned=0; Remaining=27)
   833   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C3158668:cAMP response element binding [Genetic Function]
   795   C2245434:activation of protein binding [Molecular Function]
   782   C1511573:cAMP Response Element [Gene or Genome]
   777   C2259194:activation of binding [Molecular Function]
   775   C1657589:response to cAMP [Cell Function]
   760   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   757 E C0033618:Protein Binding [Molecular Function]
   757   C0599177:protein activation [Genetic Function]
   757   C1148918:cAMP binding [Molecular Function]
   739   C0013879:Element [Element, Ion, or Isotope]
   739   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   739   C0243122:binding [Functional Concept]
   739   C0871261:Response [Organism Attribute]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   739   C1522538:Lead [Functional Concept]
   739   C1704632:Response [Finding]
   739   C1705248:Element [Conceptual Entity]
   739   C1706817:Response [Intellectual Product]
   739   C1879547:Activation [Activity]
   739   C2348269:Lead [Element, Ion, or Isotope]
   739   C2911692:Response [Mental Process]
   739   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(17-19"

Phrase: ")."
Processing 00000000.tx.22: Disruption of CREB function specifically interferes with activity-dependent synaptic plasticity ranging from long term potentiation (LTP) to long term memory (13-15). 

Phrase: "Disruption of CREB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332453:Disruption [Functional Concept]
   731   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "specifically"

Phrase: "interferes with activity-dependent synaptic plasticity ranging"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0521102:Interferes with [Qualitative Concept]
           Interfere
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0678558:Plasticity [Natural Phenomenon or Process]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1561536:*Activity [Idea or Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]
   714   C1514721:Range [Quantitative Concept]
   714   C2348147:Range [Quantitative Concept]
   714   C3542016:Range [Intellectual Product]

Phrase: "from long term potentiation (LTP)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "to long term memory"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0423909:Memory, Long-Term [Mental Process]
   901   C0443252:Long-term [Temporal Concept]
   827   C0025260:Memory [Mental Process]
   827   C0205166:Long [Qualitative Concept]
   827   C0700327:memory [Finding]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C1706377:Memory [Manufactured Object]
   827   C2826302:TERM [Intellectual Product]
   771 E C0679055:mnemonic [Mental Process]

Phrase: "(13-15"

Phrase: ")."
Processing 00000000.tx.23: It is expected, therefore, that mechanisms that interfere with CREB activation would compromise CREB activity-dependent neuronal function through disruption of downstream gene expression. 

Phrase: "It"

Phrase: "is"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "therefore,"

Phrase: "that mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "interfere with CREB activation"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   869   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C3158668:cAMP response element binding [Genetic Function]
   800   C1511573:cAMP Response Element [Gene or Genome]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0599177:protein activation [Genetic Function]
   770   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   767 E C0033618:Protein Binding [Molecular Function]
   767   C1148918:cAMP binding [Molecular Function]
   744   C0013879:Element [Element, Ion, or Isotope]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   744   C0243122:binding [Functional Concept]
   744   C0521102:Interfere [Qualitative Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1704632:Response [Finding]
   744   C1705248:Element [Conceptual Entity]
   744   C1706817:Response [Intellectual Product]
   744   C1879547:Activation [Activity]
   744   C2911692:Response [Mental Process]

Phrase: "would"

Phrase: "compromise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "CREB activity-dependent neuronal function through disruption"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0033618:Protein binding, function [Molecular Function]
   754   C0815043:function protein [Amino Acid, Peptide, or Protein]
   754   C1527118:Protein Function [Molecular Function]
   738   C0031843:function [Physiologic Function]
   738   C0521390:Neuronal [Immunologic Factor]
   738   C0542341:Function [Functional Concept]
   738   C0700205:FUNCTION [Classification]
   738   C1705273:Function [Intellectual Product]

Phrase: "of downstream gene expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.24: Brain-derived neurotrophic factor (BDNF) is one of the target genes of CREB (17, 18). 

Phrase: "Brain-derived neurotrophic factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "(BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: ")"

Phrase: "is"

Phrase: "one of the target genes of CREB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0205447:One [Quantitative Concept]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.25: BDNF, a member of the neurotrophin family, enhances survival, differentiation, and growth of certain neuronal populations, modulates synaptic activity, and acts as an effector of neuronal plasticity both during development and in the adult (20, 21). 

Phrase: "BDNF,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "a member of the neurotrophin family,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0086282:Family member [Family Group]
   783   C1611821:Family Member [Intellectual Product]
   753   C0680022:member [Population Group]
   753   C2698041:Member [Professional or Occupational Group]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "survival,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "growth of certain neuronal populations,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0032671:Population Growth [Quantitative Concept]
   797   C0814002:Neuronal Growth [Cell Function,Organism Function]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "synaptic activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "acts as an effector of neuronal plasticity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0027880:Neuronal Plasticity [Organ or Tissue Function]
   748   C0079613:ACT [Therapeutic or Preventive Procedure]
   748   C0521390:Neuronal [Immunologic Factor]
   748   C0678558:Plasticity [Natural Phenomenon or Process]

Phrase: "both during development"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0238767:Both [Spatial Concept]
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   790   C1706086:Both [Qualitative Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "and in the adult"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001675:Adult [Age Group]
   770   C1515981:And [Idea or Concept]
   770   C1706450:Adult [Human]

Phrase: "(20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.26: BDNF participates in LTP, is up-regulated in the hippocampus during learning (22), and deficits in BDNF compromise LTP and learning and memory (20). 

Phrase: "BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "participates in LTP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   862   C2984294:Long-term potentiation [Functional Concept]
   806   C0443252:Long-term [Temporal Concept]
   760   C0205166:Long [Qualitative Concept]
   760   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   760   C1515273:Term [Temporal Concept]
   760   C1705313:Term [Idea or Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C2826302:TERM [Intellectual Product]

Phrase: "is"

Phrase: "up-regulated in the hippocampus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C0949582:Hippocampus [Fish]
   760   C1029104:Hippocampus [Fish]
   760   C1282911:Up [Spatial Concept]
   760   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "during learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "deficits in BDNF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C2987487:deficits [Qualitative Concept]
   719 E C0162429:Deficit, NOS [Disease or Syndrome]
   716   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "compromise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "LTP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "and"

Phrase: "learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.27: BDNF mRNA and protein are reduced in the hippocampus in AD (23-25), a reduction proposed to contribute to cognitive decline observed in AD. 

Phrase: "BDNF mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "reduced in the hippocampus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   770   C0392756:Reduced [Qualitative Concept]
   770   C0949582:Hippocampus [Fish]
   770   C1029104:Hippocampus [Fish]
   770   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "in AD (23-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "a reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to cognitive decline"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
   770   C1516691:Cognitive [Functional Concept]
   770   C1880177:Contribute [Activity]

Phrase: "observed in AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]
Processing 00000000.tx.28: Thus, examination of BDNF transcription provides a means of assessment of effects on CREB regulation, which may play a significant role in the pathogenesis of AD. 

Phrase: "Thus,"

Phrase: "examination of BDNF transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   774   C0555351:Brain examination [Diagnostic Procedure]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a means of assessment of effects"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C1704970:Means [Conceptual Entity]
   719 E C0444504:Mean [Quantitative Concept]
   719 E C2347634:Mean [Quantitative Concept]
   719 E C2348143:Mean [Quantitative Concept]

Phrase: "on CREB regulation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0851285:Regulation [Governmental or Regulatory Activity]
   799   C1327622:Regulation [Biologic Function]
   780   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C3158668:cAMP response element binding [Genetic Function]

Phrase: "which"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a significant role in the pathogenesis of AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.29: Here, we report that levels of A-(1-42), which do not affect the survival of cortical neurons, may indeed interfere with functions critical for neuronal plasticity, by eliciting a reduction of the activity-dependent phosphorylation of CREB and the expression of BDNF, one of the important target genes of this transcription factor.  

Phrase: "Here,"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that levels of A-"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the survival of cortical neurons,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1819944:neuron survival [Cell Function]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "may"

Phrase: "indeed"

Phrase: "interfere with functions"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0521102:Interfere [Qualitative Concept]
   790   C0542341:Functions [Functional Concept]
   756 E C0031843:function [Physiologic Function]
   756 E C0700205:FUNCTION [Classification]
   756 E C1705273:Function [Intellectual Product]
   706 E C0205245:Functional [Functional Concept]
   706 E C2700217:Functional [Conceptual Entity]

Phrase: "critical for neuronal plasticity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]

Phrase: "by eliciting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0449265:elicit [Qualitative Concept]

Phrase: "a reduction of the activity-dependent phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C2267000:Reduction Activity [Molecular Function]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "the expression of BDNF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "one of the important target genes of this transcription factor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205447:One [Quantitative Concept]
Processing 00000000.tx.30: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Cell Culture-- Cultures greatly enriched in cortical neurons from embryonic day 18rat fetuses were prepared as described previously (26). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "greatly"

Phrase: "enriched in cortical neurons"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0001613:Cortical [Body Part, Organ, or Organ Component]
   770   C0007776:Cortical [Body Part, Organ, or Organ Component]
   770   C0022655:Cortical [Body Part, Organ, or Organ Component]
   770   C0027882:Neurons [Cell]
   770   C0359583:enriched [Food]
   715 E C0234875:bark [Organism Attribute]
   715 E C2700441:Bark [Plant]

Phrase: "from embryonic day 18rat fetuses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0015965:Fetuses [Embryonic Structure]
   812   C2708510:# Fetuses [Clinical Attribute]
   779 E C0242291:FETUS [Tissue]
   779 E C1305737:Fetus [Anatomical Structure]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.31: Cells plated at 2.5104 cells/cm2 were cultured in poly-L-lysine-treated multiwell plates and maintained in serum-free optimal Dulbecco's modified Eagle's medium supplemented with B-27 components (Life Technologies). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "plated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005971:Plate [Medical Device]
   966   C1139930:plate [Medical Device]
   966   C3537155:Plate [Manufactured Object]

Phrase: "at 2.5104 cells/cm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439479:cm2 [Quantitative Concept]
   804   C0555206:CM2 [Congenital Abnormality]

Phrase: "were"

Phrase: "cultured in poly-L-lysine-treated multiwell plates"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   750   C0180454:culture plates [Medical Device]
   744   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0332293:treated [Therapeutic or Preventive Procedure]
   744   C0747726:POLY [Conceptual Entity]
   744   C1139930:plates [Medical Device]
   744   C1522326:Treated [Functional Concept]
   711 E C0005971:Plate [Medical Device]
   711   C0010453:Culture [Idea or Concept]
   711   C0220814:culture [Functional Concept]
   711   C0430400:Culture [Laboratory Procedure]
   711 E C1292734:TREAT [Functional Concept]
   711   C2242979:Culture [Laboratory Procedure]
   711 E C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "maintained in serum-free optimal Dulbecco's modified Eagle's medium"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   742   C0009458:Medium [Intellectual Product]
   742   C0229671:Serum [Body Substance]
   742   C0325564:Eagle [Bird]
   742   C0332296:free [Functional Concept]
   742   C0392747:Modified [Functional Concept]
   742   C0439536:Medium [Quantitative Concept]
   742   C1314677:Maintained [Functional Concept]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   742   C1551720:Eagle [Population Group]
   742   C1705217:Medium [Substance]
   742   C1880497:Free [Qualitative Concept]
   742   C1996904:Free [Qualitative Concept]
   742   C2698651:Optimal [Qualitative Concept]
   742   C3244283:medium [Intellectual Product]
   708 E C0024501:Maintain [Activity]

Phrase: "supplemented with B-27 components"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0449432:Components [Manufactured Object]
   726   C0242295:Supplement [Food]
   726 E C1705248:Component [Conceptual Entity]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "(Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.32: When cells were exposed to A, the medium was switched to Dulbecco's modified Eagle's medium/B27 containing A. 

Phrase: "When"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "switched to Dulbecco's modified Eagle's medium/B27 containing A."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0009458:Medium [Intellectual Product]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0325564:Eagle [Bird]
   742   C0332256:Containing [Functional Concept]
   742   C0392747:Modified [Functional Concept]
   742   C0439536:Medium [Quantitative Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1537935:B27 [Gene or Genome]
   742   C1551720:Eagle [Population Group]
   742   C1705217:Medium [Substance]
   742   C2700400:Containing [Activity]
   742   C3244283:medium [Intellectual Product]
   708   C1707719:Switch [Manufactured Object]
Processing 00000000.tx.33: Cultures were maintained for 5days before treatments. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "maintained for 5days"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "before treatments."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0087111:Treatments [Therapeutic or Preventive Procedure]
   966 E C0039798:treatment [Functional Concept]
   966 E C1522326:Treatment [Functional Concept]
   966 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   966 E C1705169:Treatment [Conceptual Entity]
   966 E C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.34: Neuronal survival was assessed by trypan blue exclusion (26) and in select experiments using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (27) and annexin V binding to externalized phosphatidylserine to monitor early changes in putative apoptotic processes (28); 

Phrase: "Neuronal survival"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1819944:neuron survival [Cell Function]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "was"

Phrase: "assessed by trypan blue exclusion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0041213:Trypan Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C1260957:Blue [Qualitative Concept]
   760   C1516048:Assessed [Activity]
   760   C1565627:Trypan [Organic Chemical]
   760   C2828389:Exclusion [Activity]

Phrase: "(26"

Phrase: ")"

Phrase: "and in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "select"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Select [Activity]

Phrase: "experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(4,"

Phrase: "5-dimethylthiazol-2-yl"

Phrase: ")-"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyltetrazolium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006222:Bromide [Inorganic Chemical]

Phrase: "(MTT) assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "(27"

Phrase: ")"

Phrase: "and"

Phrase: "annexin V binding to externalized phosphatidylserine to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1323272:phosphatidylserine binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "early changes in putative apoptotic processes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "(28"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.35: these methods gave comparable results. 

Phrase: "these methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "comparable results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.36: Tetrodotoxin (1M) was added 2h before treatments to reduce endogenous synaptic activity. 

Phrase: "Tetrodotoxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039705:Tetrodotoxin [Biologically Active Substance,Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "(1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "2h before treatments to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1292425:2H [Temporal Concept]

Phrase: "reduce"

Phrase: "endogenous synaptic activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.37: Cells were stimulated using either 30mM KCl (high K+) for 15min or 10M NMDA for 10min. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either 30mM KCl"

Phrase: "(high K+) for 15min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1708601:K' [Quantitative Concept]

Phrase: "or"

Phrase: "10M NMDA for 10min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.38: Amino-5-phosphonovaleric acid (100M) was added to the cultures 30min before the high K+ exposure. 

Phrase: "Amino-5-phosphonovaleric acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   902   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "(100M"

Phrase: ")"

Phrase: "was"

Phrase: "added to the cultures 30min"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   760   C0010453:Cultures [Idea or Concept]
   760   C1524062:Added [Functional Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C1883712:Add [Functional Concept]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "before the high K+ exposure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]
Processing 00000000.tx.39: A Preparation-- A peptides were synthesized by solid-phase N-(9-fluorenyl)methoxycarbonyl (Fmoc) amino acid chemistry, purified by reverse-phase high performance liquid chromatography, and characterized by electrospray mass spectrometry as described previously (26, 29). 

Phrase: "A Preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "--"

Phrase: "A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "synthesized by solid-phase N-(9-fluorenyl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205208:Solid [Qualitative Concept]
   748   C0205390:Phase [Temporal Concept]
   748   C0302909:Solid [Substance]
   748   C1378566:Solid [Biomedical or Dental Material]
   748   C1883254:Synthesized [Activity]

Phrase: ")"

Phrase: "methoxycarbonyl"

Phrase: "(Fmoc"

Phrase: ")"

Phrase: "amino acid chemistry,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0007996:Chemistry [Occupation or Discipline]
   827   C0079107:chemistry [Classification]
   827   C0201682:Chemistry [Laboratory Procedure]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "purified by reverse-phase high performance liquid chromatography,"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   833   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   833   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   833   C1579831:High performance liquid chromatography [Functional Concept]
   819   C2717789:Reverse-Phase Liquid Chromatography [Laboratory Procedure]
   793   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   770   C0008565:Liquid Chromatography [Laboratory Procedure]
   744   C0008550:Chromatography [Laboratory Procedure]
   744   C0205250:High [Qualitative Concept]
   744   C0205390:Phase [Temporal Concept]
   744   C0302908:Liquid [Substance]
   744   C0597198:Performance [Individual Behavior]
   744   C1299351:High [Qualitative Concept]
   744   C1304698:Liquid [Finding]
   744   C1546699:Liquid NOS [Intellectual Product]
   744   C1555029:Reverse [Idea or Concept]
   744   C1561501:Liquid NOS [Substance]
   744   C1882330:Performance [Activity]
   744   C1998793:Purified [Functional Concept]
   744   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "characterized by electrospray mass spectrometry"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0037813:Mass Spectrometry [Laboratory Procedure]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C1880022:Characterized [Activity]
   760   C3152252:Mass [Quantitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(26,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.40: A stock solution of A-(1-42) (1mM) was prepared in distilled water and used after one freeze-thaw cycle. 

Phrase: "A stock solution of A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(1mM"

Phrase: ")"

Phrase: "was"

Phrase: "prepared in distilled water"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C0681549:distilled [Occupational Activity]
   770   C1550678:Water [Inorganic Chemical]
   737   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "used after one freeze-thaw cycle."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0016701:Freeze [Natural Phenomenon or Process]
   753   C0205447:One [Quantitative Concept]
   753   C1273517:used [Finding]
   753   C1511572:Cycle [Temporal Concept]
   753   C1710378:Thaw [Laboratory Procedure]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.41: We have documented previously that A-(1-42) peptides prepared this way assemble into -sheet fibrils as determined by thioflavin staining, circular dichroism, electron microscopy, and sodium dodecyl sulfate-polyacrylamide gel electrophoresis and are toxic to nerve cells (26, 29, 30). 

Phrase: "We"

Phrase: "have"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "previously"

Phrase: "that A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "this way"

Phrase: "assemble into -sheet fibrils"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0225328:fibrils [Cell Component]
   770   C1706853:Assemble [Activity]
   770   C2349187:Sheet [Quantitative Concept]
   737 E C1948066:Fibril [Physical Object]

Phrase: "as"

Phrase: "determined by thioflavin staining,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0487602:Staining [Laboratory Procedure]
   770   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1704680:Staining [Finding]

Phrase: "circular dichroism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008813:Circular Dichroism [Laboratory Procedure]
   861   C0596436:dichroism [Natural Phenomenon or Process]
   861   C1282913:Circular [Spatial Concept]

Phrase: "electron microscopy,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0026019:Electron Microscopy [Laboratory Procedure]
  1000   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   861   C0013852:Electron [Quantitative Concept]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C3463986:Electron [Bird]
   789 E C0013850:Electronic [Manufactured Object]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C1547561:Electronic [Idea or Concept]

Phrase: "and"

Phrase: "sodium dodecyl sulfate-polyacrylamide gel electrophoresis"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
  1000   C0600209:Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis [Laboratory Procedure,Research Activity]
   861   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   861   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   839   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   827   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   827   C0596607:Gel Electrophoresis [Laboratory Procedure]
   799   C0013855:Electrophoresis [Laboratory Procedure]
   799   C0017243:Gel [Biomedical or Dental Material]
   799   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   799   C0038720:Sulfate [Inorganic Chemical]
   799   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   799   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   799   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   799   C1382104:Gel [Substance]
   799   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "are"

Phrase: "toxic to nerve cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600688:toxic [Injury or Poisoning]
   770   C1407029:Toxic [Qualitative Concept]

Phrase: "(26,"

Phrase: "29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.42: To facilitate comparisons, preparations of A-derived diffusible ligands (ADDL) were obtained from the same lot of A-(1-42) peptides as the -sheet containing A-(1-42) preparations described above. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "comparisons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Comparison [Activity]

Phrase: "preparations of A-derived diffusible ligands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0455052:Preparation [Health Care Activity]
   719   C1521827:Preparation [Functional Concept]

Phrase: "(ADDL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412232:ADDL [Gene or Genome]
  1000   C2698510:ADDL [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "obtained from the same lot of A-"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0445247:Same [Qualitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1115660:LOT [Intellectual Product]
   748   C1301820:Obtained [Functional Concept]
   748   C1518000:Lot [Qualitative Concept]
   748   C1710198:Lot [Idea or Concept]
   714 E C1706701:Obtain [Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "peptides as the -sheet containing A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0455052:Preparation [Health Care Activity]
   966   C1521827:Preparation [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.43: Solutions of ADDLs were prepared as described previously (31, 32). 

Phrase: "Solutions of ADDLs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0037633:Solutions [Substance]
   756 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.44: In brief, A-(1-42)-containing solutions (0.34mg/ml) were incubated with clusterin (0.17mg/ml) at 22C for 24h. 

Phrase: "In brief, A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "containing solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037633:Solutions [Substance]
   827 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "(0.34mg/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with clusterin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0055966:Clusterin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C1413514:CLUSTERIN [Gene or Genome]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "(0.17mg/ml) at 22C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "for 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.45: Solutions were centrifuged at 14,000g for 10min to remove large aggregates, and the supernatant was used for all assays. 

Phrase: "Solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "centrifuged at 14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 10min to"

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "large aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "used for all assays."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C1273517:used [Finding]
   737   C0005507:Assay [Laboratory Procedure]
   737 E C0042153:use [Functional Concept]
   737   C0243073:assay [Qualitative Concept]
   737 E C0457083:Use [Functional Concept]
   737   C1510438:Assay [Laboratory Procedure]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.46: In agreement with the published features of these preparations, microscopic examination indicated that the supernatant contained no large aggregates. 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with the published features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "of these preparations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0455052:Preparation [Health Care Activity]
   966   C1521827:Preparation [Functional Concept]

Phrase: "microscopic examination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026018:Microscopic examination [Laboratory Procedure]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "no large aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.47: Western Blotting-- Cortical neurons were lysed in SDS sample buffer, and the proteins were resolved by SDS- polyacrylamide gel electrophoresis (10% acrylamide) and transferred to polyvinylidene difluoride membrane. 

Phrase: "Western Blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "--"

Phrase: "Cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "lysed in SDS sample buffer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:lysed [Pathologic Function]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "resolved by SDS- polyacrylamide gel electrophoresis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   753   C1514893:Resolved [Idea or Concept]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: "(10% acrylamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ")"

Phrase: "and"

Phrase: "transferred to polyvinylidene difluoride membrane."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membrane [Tissue]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]
Processing 00000000.tx.48: Membranes were incubated at room temperature in PBS containing 5% nonfat milk for 60min to block the nonspecific binding. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated at room temperature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1547703:Room [Spatial Concept]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5% nonfat milk for 60min to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0026131:Milk [Body Substance]
   753   C0349374:Milk [Food]
   753   C0444318:Milk [Substance]
   753   C2825079:Milk [Food]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the nonspecific binding."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
Processing 00000000.tx.49: Following incubation with the primary antibodies specific for either Ser-133 phosphorylated CREB (P-CREB) (1:2,000) or total CREB (T-CREB), which recognize both phospho- and dephospho-CREB (1:1,000) (both antibodies from Upstate Biotechnology, Inc.), the blots were washed in PBS containing 0.1% Tween and then incubated with the secondary antibody, goat anti-rabbit IgG conjugated with horseradish peroxidase (Vector Laboratories), at 1:8000 dilution in the blocking solution for 60min. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation with the primary antibodies"

Phrase: "specific for either Ser-133 phosphorylated CREB (CREB)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0205369:Specific [Qualitative Concept]
   738   C1552740:specific [Intellectual Product]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2,000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "or"

Phrase: "total CREB (T-CREB),"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   895   C0555903:Total protein [Laboratory Procedure]
   895   C1261360:total protein [Laboratory or Test Result]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "which"

Phrase: "recognize"

Phrase: "both phospho-"

Phrase: "and"

Phrase: "dephospho-CREB (1"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   954   C1413702:cAMP RESPONSE ELEMENT-BINDING PROTEIN 1 [Gene or Genome]
   913   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C3158668:cAMP response element binding [Genetic Function]
   845   C1148918:cAMP binding [Molecular Function]
   845   C1511573:cAMP Response Element [Gene or Genome]
   818   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0013879:Element [Element, Ion, or Isotope]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   795   C0243122:binding [Functional Concept]
   795   C0871261:Response [Organism Attribute]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1704632:Response [Finding]
   795   C1705248:Element [Conceptual Entity]
   795   C1706817:Response [Intellectual Product]
   795   C2911692:Response [Mental Process]

Phrase: ":"

Phrase: "1,000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "("

Phrase: "both antibodies from Upstate Biotechnology,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Inc."

Phrase: ")"

Phrase: ","

Phrase: "the blots"

Phrase: "were"

Phrase: "washed in PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% Tween"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   771 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with the secondary antibody,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0027627:secondary [Neoplastic Process]
   760   C0175668:Secondary [Temporal Concept]
   760   C0205436:Secondary [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "goat anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0034493:Rabbit [Mammal]

Phrase: "conjugated with horseradish peroxidase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0330510:Horseradish [Food]
   770   C0522529:Conjugated [Spatial Concept]
   770   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   770   C1110641:Horseradish [Plant]
   770   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   737 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(Vector Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "8000 dilution in the blocking solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079240:Dilution [Laboratory Procedure]
   753   C1948037:Dilution [Functional Concept]

Phrase: "for 60min."
Processing 00000000.tx.50: Blots were then washed four times with PBS containing 0.1% Tween. 

Phrase: "Blots"

Phrase: "were"

Phrase: "then washed four times with PBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% Tween."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   771 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.51: Immunolabeling was detected by enhanced chemiluminescence (ECL, Amersham Pharmacia Biotech) according to the recommended conditions. 

Phrase: "Immunolabeling"

Phrase: "was"

Phrase: "detected by enhanced chemiluminescence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0442726:Detected [Finding]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C2349975:Enhanced [Activity]

Phrase: "(ECL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332684:ECL [Gene or Genome]

Phrase: "Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "according to the recommended conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.52: Immunoreactivity was quantified using densitometric analysis. 

Phrase: "Immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "densitometric analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.53: Immunocytochemistry-- Cultures were initially treated with a solution of 3% aqueous H2O2 for 3min, then briefly rinsed in Tris-buffered saline (TBS, 0.05M Tris in 0.9% NaCl, pH 7.4), and incubated in TBS containing 5% normal goat serum. 

Phrase: "Immunocytochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "--"

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "treated with a solution of 3% aqueous H2O2"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   767   C3255993:aqueous solution [Pharmacologic Substance]
   744   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0037633:Solution [Substance]
   744   C0525069:Solution [Biomedical or Dental Material]
   744   C0599956:Aqueous [Qualitative Concept]
   744   C1522326:Treated [Functional Concept]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "for 3min,"

Phrase: "then briefly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "rinsed in Tris-buffered saline"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0036082:Saline [Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0814229:TRI [Intellectual Product]
   726   C1701810:Rinse [Functional Concept]
   726   C1882955:Rinse [Activity]

Phrase: "(TBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: "0.05M Tris in 0.9% NaCl,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "incubated in TBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1532188:Tbsp [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5% normal goat serum."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   812   C0018019:goat [Mammal]
   812   C0205307:Normal [Qualitative Concept]
   812   C0229671:Serum [Body Substance]
   812   C0439166:% normal [Quantitative Concept]
   812   C1265549:goat [Mammal]
   812   C1510458:Goat [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   812   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.54: The cultures were then incubated at 4C in TBS, 5% serum containing the rabbit polyclonal IgG against P-CREB (1:2000). 

Phrase: "The cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "in TBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: "5% serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the rabbit polyclonal IgG"

Phrase: "against P-CREB (1"
Meta Candidates (Total=24; Excluded=0; Pruned=0; Remaining=24)
   954   C1413702:cAMP RESPONSE ELEMENT-BINDING PROTEIN 1 [Gene or Genome]
   913   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   877   C1151818:P-protein [Molecular Function]
   877   C3158668:cAMP response element binding [Genetic Function]
   868   C1148749:P-element binding [Genetic Function]
   845   C0031705:P element [Element, Ion, or Isotope]
   845   C1148918:cAMP binding [Molecular Function]
   845   C1511573:cAMP Response Element [Gene or Genome]
   818   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0013879:Element [Element, Ion, or Isotope]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   795   C0243122:binding [Functional Concept]
   795   C0871261:Response [Organism Attribute]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1704632:Response [Finding]
   795   C1705248:Element [Conceptual Entity]
   795   C1706817:Response [Intellectual Product]
   795   C2911692:Response [Mental Process]

Phrase: ":"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.55: Cultures were then rinsed in buffer and incubated in biotinylated goat anti-rabbit IgG. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rinsed in buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   756   C1701810:Rinse [Functional Concept]
   756   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "incubated in biotinylated goat anti-rabbit IgG."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0018019:goat [Mammal]
   748   C0034493:Rabbit [Mammal]
   748   C1265549:goat [Mammal]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1510458:Goat [Mammal]
Processing 00000000.tx.56: After a buffer rinse, cultures were incubated in the presence of avidin-biotin-horseradish peroxidase complex (Vector Laboratories) for 90min. 

Phrase: "After a buffer rinse,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1701810:Rinse [Functional Concept]
   861   C1882955:Rinse [Activity]

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "incubated in the presence of avidin-biotin-horseradish peroxidase complex"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   799   C0662144:avidin-horseradish peroxidase complex [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   739   C0004434:Avidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   739   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0330510:Horseradish [Food]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C0439855:Complex [Qualitative Concept]
   739   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   739   C1110641:Horseradish [Plant]
   739   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   739   C1439852:Incubated [Laboratory Procedure]
   739   C1704241:Complex [Chemical Viewed Structurally]
   739   C2700256:Biotin [Laboratory Procedure]

Phrase: "(Vector Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "for 90min."
Processing 00000000.tx.57: They were then rinsed in 0.1M Tris-HCl, pH 7.6,and incubated in Tris-HCl containing 0.05% diaminobenzidine tetrahydrochloride and 0.01% hydrogen peroxide for 5-10 min. 

Phrase: "They"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rinsed in 0.1M Tris-HCl,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   753   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   753   C0470296:1M [Quantitative Concept]
   753   C0814229:TRI [Intellectual Product]
   719   C1701810:Rinse [Functional Concept]
   719   C1882955:Rinse [Activity]

Phrase: "pH 7.6,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "incubated in Tris-HCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   770   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   770   C0814229:TRI [Intellectual Product]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.05% diaminobenzidine tetrahydrochloride"

Phrase: "and"

Phrase: "0.01% hydrogen peroxide for 5-10 min."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0020275:Hydrogen [Element, Ion, or Isotope]
   744   C0031180:Peroxide [Inorganic Chemical]
   744   C0523702:HYDROGEN [Laboratory Procedure]
   744   C0885426:hydrogen [Inorganic Chemical]
Processing 00000000.tx.58: Reactions were stopped by rinsing the cultures with PBS. 

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "stopped by rinsing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1272691:stopped [Qualitative Concept]
   790   C1882955:Rinsing [Activity]
   756 E C1947925:Stop [Activity]
   756 E C2746065:Stop [Temporal Concept]

Phrase: "the cultures with PBS."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0010453:Cultures [Idea or Concept]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.59: Quantitative analysis was performed by Image Pro-Plus software (Media Cybernetics). 

Phrase: "Quantitative analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0392762:Quantitative [Quantitative Concept]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed by Image Pro-Plus software"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C1550369:Performed By [Qualitative Concept]
   753   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0037585:Software [Intellectual Product,Manufactured Object]
   753   C0332287:Plus [Qualitative Concept]
   753   C0884358:Performed [Functional Concept]
   753   C1704254:Image [Intellectual Product]
   753   C1704922:Image [Entity]
   753   C2987124:PRO [Intellectual Product]
   753   C3542466:Image [Intellectual Product]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Media Cybernetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010521:Cybernetics [Occupational Activity]

Phrase: ")."
Processing 00000000.tx.60: Cortical Neuron Transfection and Luciferase Assay-- Cortical neurons were transfected with plasmid pIII(170)Luc (a kind gift of Dr. Michael E.Greenberg, Harvard Medical School) at 3DIV using a procedure described previously (33). 

Phrase: "Cortical Neuron Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "Luciferase Assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "--"

Phrase: "Cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "transfected with plasmid pIII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(170"

Phrase: ")"

Phrase: "Luc"

Phrase: "("

Phrase: "a kind gift of Dr. Michael E.Greenberg,"

Phrase: "Harvard Medical School"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: ")"

Phrase: "at 3DIV"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.61: Briefly, all transfections were conducted in 6-well 35-mm dishes with LipofectAMINE (Life Technologies, Inc.) according to the manufacturer's instructions. 

Phrase: "Briefly,"

Phrase: "all transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "conducted in 6-well 35-mm dishes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205170:Well [Qualitative Concept]
   748   C3146287:Well [Manufactured Object]
   714   C0004927:Conduct [Individual Behavior]
   714   C0020498:DISH [Disease or Syndrome]

Phrase: "with LipofectAMINE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.) according to the manufacturer's instructions."
Processing 00000000.tx.62: One well was transfected with 1g of reporter plasmid and 0.1g of pRL-CMV (Promega), a cytomegalovirus-luciferase control plasmid to normalize BDNF exon III promoter activity. 

Phrase: "One well"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "transfected with 1g of reporter plasmid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0335038:Reporter [Professional or Occupational Group]
   753   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   753   C1705915:Reporter [Conceptual Entity]
   753   C1709908:Reporter [Group]

Phrase: "and"

Phrase: "0.1g of pRL-CMV (Promega"

Phrase: ")"

Phrase: ","

Phrase: "a cytomegalovirus-luciferase control plasmid to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "BDNF exon III promoter activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   892   C0443158:Brain activity [Physiologic Function]
   793   C0205177:Activity [Functional Concept]
   793   C0439167:% activity [Quantitative Concept]
   793   C0441655:Activity [Activity]
   793   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.63: Forty hours after transfection, cultures received 30mM KCl for 9h and then plates were washed twice with cold PBS, and cells were lysed with 200l of lysis buffer (Promega). 

Phrase: "Forty hours after transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "received 30mM KCl for 9h"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with cold PBS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0009264:Cold [Natural Phenomenon or Process]
   770   C0009443:Cold [Disease or Syndrome]
   770   C0234192:Cold [Physiologic Function]
   770   C1720725:Twice [Intellectual Product]
   770   C1720830:PBS [Disease or Syndrome]
   770   C1823521:PBS [Gene or Genome]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed with 200l of lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0024348:Lysis [Pathologic Function]
           lysed
   753   C1536403:lysis [Cell Function]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.64: Twenty l of cell extract were used for a dual-luciferase reporter assay (Promega) according to the manufacturer's instructions. 

Phrase: "Twenty l of cell extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C0022827:cell l [Cell]

Phrase: "were"

Phrase: "used for a dual-luciferase reporter assay"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   748   C0243073:assay [Qualitative Concept]
   748   C0335038:Reporter [Professional or Occupational Group]
   748   C1273517:used [Finding]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   748   C1554184:Dual [Intellectual Product]
   748   C1705915:Reporter [Conceptual Entity]
   748   C1709908:Reporter [Group]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.65: RT-PCR-- BDNF exon III and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA contents were estimated using RT-PCR. 

Phrase: "RT-PCR-- BDNF exon III"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   822   C0040048:Factor III [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0439070:III [Intellectual Product]
   793   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA contents"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   799   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0456205:Contents [Conceptual Entity]
   799   C1552853:contents [Idea or Concept]
   766 E C0423896:Content [Mental Process]
   734   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   734   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   700   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]

Phrase: "were"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RT-PCR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]
Processing 00000000.tx.66: Total RNA was isolated from cultures at 5DIV by a spin column kit (Promega), and RT-PCR was carried out using a one-tube RT-PCR kit (Amersham Pharmacia) following the manufacturer's instructions. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated from cultures"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0010453:Cultures [Idea or Concept]
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0220814:culture [Functional Concept]
   756 E C0370215:Isolate [Substance]
   756 E C0430400:Culture [Laboratory Procedure]
   756 E C1875400:ISOLATE [Pharmacologic Substance]
   756 E C2242979:Culture [Laboratory Procedure]

Phrase: "at 5DIV"

Phrase: "by a spin column kit (Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a one-tube RT-PCR kit (Amersham Pharmacia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.67: 100ng of total RNA was used, and the single-stranded cDNA was amplified by PCR with exon-specific primers. 

Phrase: "100ng of total RNA"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "and"

Phrase: "the single-stranded cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "with exon-specific primers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.68: The primers for BDNF exon III and GAPDH were described previously (18). 

Phrase: "The primers for BDNF exon III"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "GAPDH"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.69: BDNF exon III primers were as follows: reverse primer E5R, 5'-GAGAAGAGTGATGACCATCCT-3' and forward primer E3F (exon III-specific), 5'-TGCGAGTATTACCTCCGCCAT-3'. 

Phrase: "BDNF exon III primers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   710   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "reverse primer E5R,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]

Phrase: "5'-GAGAAGAGTGATGACCATCCT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "forward primer E3F"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1953382:Forward primer [Cell]

Phrase: "(exon III-specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205369:Specific [Qualitative Concept]
   827   C1552740:specific [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "5'-TGCGAGTATTACCTCCGCCAT-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.70: GAPDH primers were 5'-TCCATGACAACTTTGGCATCGTGG-3' and 5'-GTTGCTGTTGAAGTCACAGGAGAC-3'. 

Phrase: "GAPDH primers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   771   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   771   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   771   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   722   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   717   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]

Phrase: "were"

Phrase: "5'-TCCATGACAACTTTGGCATCGTGG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-GTTGCTGTTGAAGTCACAGGAGAC-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.71: The amount of total RNA in the samples was normalized to the amount of GAPDH. 

Phrase: "The amount of total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "in the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "normalized to the amount of GAPDH."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   818   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   818   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   784   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   742   C0017854:Glyceraldehyde [Carbohydrate]
   742   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   742   C0031701:phosphate [Organophosphorus Compound]
   742   C1265611:Amount [Quantitative Concept]
   742   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   742   C1882115:Normalized [Research Activity]
Processing 00000000.tx.72: The PCR products were separated by electrophoresis on 6% polyacrylamide gels and stained using Vistra Green (Amersham Pharmacia Biotech). 

Phrase: "The PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated by electrophoresis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "on 6% polyacrylamide gels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   827   C0017243:Gels [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   793 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Vistra Green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332583:Green [Qualitative Concept]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.73: The products were quantified by PhosphorImager (Molecular Dynamics) analysis.  

Phrase: "The products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "quantified by PhosphorImager"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "(Molecular Dynamics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: ")"

Phrase: "analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]
Processing 00000000.tx.74: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Low Concentrations of A-(1-42) Decrease Neuronal Activity-dependent Phosphorylation of CREB-- -Amyloid peptides, such as A-(1-42) and A-(25-35), are known to compromise neuronal survival both in vitro and in vivo (8, 34). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Low Concentrations of A-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "Neuronal Activity-dependent Phosphorylation of CREB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   739   C0031715:Phosphorylation [Molecular Function]

Phrase: "-- -"

Phrase: "Amyloid peptides,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "such as A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: ","

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compromise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "neuronal survival"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1819944:neuron survival [Cell Function]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(8,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.75: The effect of A-(1-42) on cultured neurons is concentration-dependent, and significant cell loss was detected after treatment at concentrations of >20 M. 

Phrase: "The effect of A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "on cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "is"

Phrase: "concentration-dependent,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0086045:Concentration [Mental Process]
   861   C0851827:Dependent [Qualitative Concept]
   861   C1446561:Concentration [Quantitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "significant cell loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517945:Loss [Quantitative Concept]

Phrase: "was"

Phrase: "detected after treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0001758:After-Treatment [Health Care Activity]
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "at concentrations of >20 M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.76: We also observed that under our experimental conditions there was a threshold for the effect of A-(1-42) on cell viability. 

Phrase: "We also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that under our experimental conditions there"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1517586:Experimental [Qualitative Concept]
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "was"

Phrase: "a threshold for the effect of A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449864:Threshold [Qualitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "on cell viability."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.77: Twenty four-hour exposure of cortical neurons to A-(1-42) at 20 M with the lot of peptide used in this study resulted in significant cell loss, whereas survival was not affected at 10 M (not shown). 

Phrase: "Twenty four-hour exposure of cortical neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332157:Exposure [Clinical Attribute]

Phrase: "to A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "at 20 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "with the lot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1115660:LOT [Intellectual Product]
  1000   C1518000:Lot [Qualitative Concept]
  1000   C1710198:Lot [Idea or Concept]

Phrase: "of peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "resulted in significant cell loss,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0007634:Cell [Cell]
   760   C0237881:significant [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1269647:Cell [Cell]
   760   C1517945:Loss [Quantitative Concept]
   760   C1546944:Significant [Qualitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "whereas"

Phrase: "survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected at 10"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]

Phrase: "M ("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.78: A concentration range of 1-10 M was therefore chosen for the exploration of the influence of A-(1-42) on neuronal function. 

Phrase: "A concentration range of 1-10 M"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1514721:Range [Quantitative Concept]
   748   C2348147:Range [Quantitative Concept]
   748   C3542016:Range [Intellectual Product]

Phrase: "was"

Phrase: "therefore"

Phrase: "chosen for the exploration of the influence of A-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1280903:Exploration [Therapeutic or Preventive Procedure]
   742   C1707391:Chosen [Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "on neuronal function."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0031843:function [Physiologic Function]
   861   C0521390:Neuronal [Immunologic Factor]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0027882:Neuron [Cell]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.79: It should be noted that no studies to date have assessed the effect of sublethal levels of A on the regulation of gene expression that is mediated by activity-dependent signal transduction. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "no studies to date"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   802   C2348558:Study Date [Temporal Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the effect of sublethal levels of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "is"

Phrase: "mediated by activity-dependent signal transduction."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0037083:Signal Transduction [Cell Function]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1160185:transduction [Organism Function]
   753   C1561536:*Activity [Idea or Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C1710082:Signal [Phenomenon or Process]
   753   C3244310:dependent [Functional Concept]
Processing 00000000.tx.80: Cognitive dysfunction is a characteristic feature of the AD phenotype. 

Phrase: "Cognitive dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "is"

Phrase: "a characteristic feature of the AD phenotype."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.81: Recent studies have demonstrated that synaptic plasticity, including certain forms of LTP and memory, depends critically on the activation of the transcription factor CREB (13-15). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that synaptic plasticity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0032167:Plastic [Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "certain forms of LTP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "memory,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "depends"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0725813:depend [Medical Device]

Phrase: "critically on the activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "of the transcription factor CREB"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   913   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1149367:transcription factor binding [Genetic Function]
   877   C3158668:cAMP response element binding [Genetic Function]
   845   C1148918:cAMP binding [Molecular Function]
   845   C1511573:cAMP Response Element [Gene or Genome]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0013879:Element [Element, Ion, or Isotope]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   795   C0243122:binding [Functional Concept]
   795   C0871261:Response [Organism Attribute]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1704632:Response [Finding]
   795   C1705248:Element [Conceptual Entity]
   795   C1706817:Response [Intellectual Product]
   795   C2911692:Response [Mental Process]

Phrase: "(13-15"

Phrase: ")."
Processing 00000000.tx.82: Therefore, we examined the influence of sublethal concentrations of A-(1-42) on activity-dependent CREB phosphorylation. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the influence of sublethal concentrations of A-"

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "on activity-dependent CREB phosphorylation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   793   C0031715:Phosphorylation [Molecular Function]
   723   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.83: K+-induced depolarization of neurons is known to elicit the phosphorylation of CREB at Ser-133, an event that is essential for its transcription-activating function (16-18). 

Phrase: "K+-induced depolarization of neurons"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "the phosphorylation of CREB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   744   C0031715:Phosphorylation [Molecular Function]
   703   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at Ser-133,"

Phrase: "an event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441471:Event [Event]

Phrase: "that"

Phrase: "is"

Phrase: "essential for its transcription-activating function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205224:Essential [Qualitative Concept]

Phrase: "(16-18"

Phrase: ")."
Processing 00000000.tx.84: Therefore, the level of activated CREB was examined with Western blotting using a specific antibody against Ser-133-phosphorylated CREB (P-CREB). 

Phrase: "Therefore,"

Phrase: "the level of activated CREB"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0428479:Protein level [Laboratory or Test Result]
   762   C1547597:Response level [Idea or Concept]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "examined with Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0332128:Examined [Finding]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a specific antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against Ser-133-phosphorylated CREB"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   890   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   878   C2753988:Ser binding [Molecular Function]
   861   C3158668:cAMP response element binding [Genetic Function]
   836   C1148918:cAMP binding [Molecular Function]
   835   C1511573:cAMP Response Element [Gene or Genome]
   812   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0013879:Element [Element, Ion, or Isotope]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   793   C0243122:binding [Functional Concept]
   793   C0871261:Response [Organism Attribute]
   793   C1145667:Binding [Activity]
   793   C1167622:Binding [Molecular Function]
   793   C1704632:Response [Finding]
   793   C1705248:Element [Conceptual Entity]
   793   C1706817:Response [Intellectual Product]
   793   C2911692:Response [Mental Process]

Phrase: "(P-CREB"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   895   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   895   C1151818:P-protein [Molecular Function]
   885   C1148749:P-element binding [Genetic Function]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C0031705:P element [Element, Ion, or Isotope]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: ")."
Processing 00000000.tx.85: Pretreatment with 5or 10M A-(1-42) for 1h decreased high K+-induced elevation of the amount of P-CREB (Fig. 1, A and B). 

Phrase: "Pretreatment with 5or 10M A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1550147:Pretreatment [Substance]
   760   C2709094:pre treatment [Temporal Concept]
   760   C3539075:Pretreatment [Temporal Concept]
   760   C3539076:Pretreatment [Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "high K+-induced elevation of the amount"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439775:Elevation [Therapeutic or Preventive Procedure]
   748   C0702240:Elevation [Spatial Concept]

Phrase: "of P-CREB"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   895   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   895   C1151818:P-protein [Molecular Function]
   885   C1148749:P-element binding [Genetic Function]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C0031705:P element [Element, Ion, or Isotope]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.86: Pretreatment with 5or 10M A-(1-42) for 1h on unstimulated cells had no significant effect on the basal level of P-CREB (as a percentage of control the values after exposure to 5or 10M A-(1-42) 11533and 12021%) (Fig. 1C). 

Phrase: "Pretreatment with 5or 10M A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1550147:Pretreatment [Substance]
   760   C2709094:pre treatment [Temporal Concept]
   760   C3539075:Pretreatment [Temporal Concept]
   760   C3539076:Pretreatment [Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "on unstimulated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "no significant effect on the basal level"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "of P-CREB"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   895   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   895   C1151818:P-protein [Molecular Function]
   885   C1148749:P-element binding [Genetic Function]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C0031705:P element [Element, Ion, or Isotope]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "("

Phrase: "as a percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439165:Percentage [Quantitative Concept]
  1000   C1549488:Percentage [Idea or Concept]
  1000   C1561533:Percentage [Idea or Concept]

Phrase: "of"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the values after exposure"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "to 5or 10M A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "11533and 12021%"

Phrase: ")"

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.87: View larger version (26K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.88: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.89: Treatment with A-(1-42) decreased high K+-induced CREB phosphorylation in cultured cortical neurons. 

Phrase: "Treatment with A-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "high K+-induced CREB phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   807   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   791   C0031715:Phosphorylation [Molecular Function]
   707   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in cultured cortical neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.90: CREB activation was examined using an antibody against Ser-133-phosphorylated CREB (P-CREB). 

Phrase: "CREB activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0599177:protein activation [Genetic Function]
   799   C1879547:Activation [Activity]
   780   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C3158668:cAMP response element binding [Genetic Function]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against Ser-133-phosphorylated CREB"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   890   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   878   C2753988:Ser binding [Molecular Function]
   861   C3158668:cAMP response element binding [Genetic Function]
   836   C1148918:cAMP binding [Molecular Function]
   835   C1511573:cAMP Response Element [Gene or Genome]
   812   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0013879:Element [Element, Ion, or Isotope]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   793   C0243122:binding [Functional Concept]
   793   C0871261:Response [Organism Attribute]
   793   C1145667:Binding [Activity]
   793   C1167622:Binding [Molecular Function]
   793   C1704632:Response [Finding]
   793   C1705248:Element [Conceptual Entity]
   793   C1706817:Response [Intellectual Product]
   793   C2911692:Response [Mental Process]

Phrase: "(P-CREB"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   895   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   895   C1151818:P-protein [Molecular Function]
   885   C1148749:P-element binding [Genetic Function]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C0031705:P element [Element, Ion, or Isotope]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: ")."
Processing 00000000.tx.91: A, Western blot analysis of CREB. 

Phrase: "A,"

Phrase: "Western blot analysis of CREB."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   764   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   762   C1514534:Protein Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
   742   C1705493:Western [Spatial Concept]
Processing 00000000.tx.92: In comparison with control, the amount of P-CREB increased by exposing cortical neuronal cultures to 30mM KCl for 15min. 

Phrase: "In comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "with control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the amount of P-CREB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:Amount [Quantitative Concept]

Phrase: "increased by exposing cortical neuronal cultures"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0001613:Cortical [Body Part, Organ, or Organ Component]
   753   C0007776:Cortical [Body Part, Organ, or Organ Component]
   753   C0010453:Cultures [Idea or Concept]
   753   C0022655:Cortical [Body Part, Organ, or Organ Component]
   753   C0205217:Increased [Quantitative Concept]
   753   C0332157:exposing [Clinical Attribute]
   753   C0442805:Increased [Functional Concept]
   753   C0521390:Neuronal [Immunologic Factor]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "to 30mM KCl"

Phrase: "for 15min."
Processing 00000000.tx.93: Pretreatment with sublethal concentrations of A-(1-42) (5or 10M) for 1h resulted in a decrease in the amount of P-CREB. 

Phrase: "Pretreatment with sublethal concentrations of A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1550147:Pretreatment [Substance]
   753   C2709094:pre treatment [Temporal Concept]
   753   C3539075:Pretreatment [Temporal Concept]
   753   C3539076:Pretreatment [Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(5or 10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "resulted in a decrease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "in the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of P-CREB."
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   895   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   895   C1151818:P-protein [Molecular Function]
   885   C1148749:P-element binding [Genetic Function]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C0031705:P element [Element, Ion, or Isotope]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
Processing 00000000.tx.94: B, quantification of levels of P-CREB and T-CREB obtained in three independent experiments shows that A-(1-42) treatment resulted in a concentration-dependent suppression of the K+-induced elevation of P-CREB content (*, p<0.05) but had no significant effect on the level of total CREB (C, control; K, 30mM KCl; A1, A5, and A10,- 30mM KCl after pretreatment with 1,5,and 10M A-(1-42), respectively). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantification of levels of P-CREB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1709793:Quantification [Quantitative Concept]

Phrase: "and"

Phrase: "T-CREB"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   895   C0103013:T-protein [Amino Acid, Peptide, or Protein,Enzyme]
   895   C0170844:T Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   895   C1152257:T-protein [Molecular Function]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "obtained in three independent experiments"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0085862:Independent [Idea or Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1299583:Independent [Finding]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1706701:Obtain [Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "resulted in a concentration-dependent suppression of the K+-induced elevation"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   738   C0086045:Concentration [Mental Process]
   738   C0205263:Induced [Functional Concept]
   738   C0221103:Suppression [Pathologic Function]
   738   C0301625:Suppression [Organism Function]
   738   C0439181:% suppression [Quantitative Concept]
   738   C0439775:Elevation [Therapeutic or Preventive Procedure]
   738   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   738   C0702240:Elevation [Spatial Concept]
   738   C0728721:suppression [Mental Process]
   738   C0851827:Dependent [Qualitative Concept]
   738   C1446561:Concentration [Quantitative Concept]
   738   C1701901:Dependent [Qualitative Concept]
   738   C1708601:K' [Quantitative Concept]
   738   C3244310:dependent [Functional Concept]
   704   C1274040:Result [Functional Concept]
   704   C1546471:Result [Idea or Concept]
   704   C2825142:Result [Finding]

Phrase: "of P-CREB content"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   795   C0423896:Content [Mental Process]
   795   C0456205:Content [Conceptual Entity]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1151818:P-protein [Molecular Function]
   710   C3158668:cAMP response element binding [Genetic Function]
   701   C1148749:P-element binding [Genetic Function]

Phrase: "("

Phrase: "*,"

Phrase: "p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "but"

Phrase: "had"

Phrase: "no significant effect on the level"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "of total CREB"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   895   C0555903:Total protein [Laboratory Procedure]
   895   C1261360:total protein [Laboratory or Test Result]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "(C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "; K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "30mM KCl"

Phrase: "; A1,"

Phrase: "A5,"

Phrase: "and"

Phrase: "A10,-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]

Phrase: "30mM KCl after pretreatment"

Phrase: "with 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "10M A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.95: C, pretreatment with 5or 10M A-(1-42) for 1h on unstimulated cells had no significant effect on the basal level of P-CREB. 

Phrase: "C,"

Phrase: "pretreatment with 5or 10M A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1550147:Pretreatment [Substance]
   760   C2709094:pre treatment [Temporal Concept]
   760   C3539075:Pretreatment [Temporal Concept]
   760   C3539076:Pretreatment [Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "on unstimulated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "no significant effect on the basal level"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "of P-CREB."
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   895   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   895   C1151818:P-protein [Molecular Function]
   885   C1148749:P-element binding [Genetic Function]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C0031705:P element [Element, Ion, or Isotope]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
Processing 00000000.tx.96: D, pretreatment with 5M A-(1-42) for 1and 24h decreased the amount of P-CREB in high K+-treated cells. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "pretreatment with 5M A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "for 1and 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456696:/24h [Temporal Concept]
   861   C1442770:24H [Temporal Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the amount of P-CREB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:Amount [Quantitative Concept]

Phrase: "in high K+-treated cells."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   875   C0022686:k cells [Cell]
   858 E C0022688:K cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.97: E, pretreatment with 10M A-(1-42) with random sequence A(R) had no significant influence on the high K+-induced increase of P-CREB levels. 

Phrase: "E,"

Phrase: "pretreatment with 10M A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "with random sequence A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(R)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "had"

Phrase: "no significant influence on the high K+-induced increase"

Phrase: "of P-CREB levels."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   845   C1547597:Response level [Idea or Concept]
   795   C0441889:Levels [Qualitative Concept]
   785   C0428479:Protein level [Laboratory or Test Result]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1151818:P-protein [Molecular Function]
   710   C3158668:cAMP response element binding [Genetic Function]
   701   C1148749:P-element binding [Genetic Function]
Processing 00000000.tx.98: Similar results were obtained in three independent experiments. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained in three independent experiments."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0085862:Independent [Idea or Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1299583:Independent [Finding]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.99: The main effect of A-(1-42) on the depolarization-induced elevation of P-CREB occurred within the 1st h, and in cultures exposed to high K+ for 15min the P-CREB level was, as a percentage of that in the untreated controls, 503.0or 402.0% after treatment with 5M A-(1-42) for 1or 24h (Fig. 1D; n=3). 

Phrase: "The main effect of A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205225:Main [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C1542147:Main [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "on the depolarization-induced elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439775:Elevation [Therapeutic or Preventive Procedure]
   827   C0702240:Elevation [Spatial Concept]

Phrase: "of P-CREB"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   895   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   895   C1151818:P-protein [Molecular Function]
   885   C1148749:P-element binding [Genetic Function]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C0031705:P element [Element, Ion, or Isotope]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "occurred within the 1st h,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0205435:1st [Quantitative Concept]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C1709305:Occurred [Activity]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "and in cultures"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0010453:Cultures [Idea or Concept]
   790   C1515981:And [Idea or Concept]
   756 E C0220814:culture [Functional Concept]
   756 E C0430400:Culture [Laboratory Procedure]
   756 E C2242979:Culture [Laboratory Procedure]

Phrase: "exposed to high K+"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0205250:High [Qualitative Concept]
   770   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1299351:High [Qualitative Concept]
   770   C1708601:K' [Quantitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "for 15min"

Phrase: "the P-CREB level"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   861   C1547597:Response level [Idea or Concept]
   818   C0428479:Protein level [Laboratory or Test Result]
   795   C0441889:Level [Qualitative Concept]
   795   C0456079:Level [Classification]
   795   C1547707:Level [Geographic Area]
   795   C2946261:Level [Pharmacologic Substance]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1151818:P-protein [Molecular Function]
   710   C3158668:cAMP response element binding [Genetic Function]
   701   C1148749:P-element binding [Genetic Function]

Phrase: "was"

Phrase: ","

Phrase: "as"

Phrase: "a percentage of that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "in the untreated controls,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0332155:untreated [Finding]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "503.0or 402.0% after treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0001758:After-Treatment [Health Care Activity]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with 5M A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "for 1or 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456696:/24h [Temporal Concept]
   861   C1442770:24H [Temporal Concept]

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: "; n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.100: In contrast, the effect of A-(1-42) with random sequence (A-(1-42)(R)) failed to influence the high K+-induced increase of P-CREB levels (Fig. 1E). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the effect of A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "with random sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0034656:RANDOM [Research Activity]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0439605:Random [Qualitative Concept]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "(A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(R))"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "the high K+-induced increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:Increase [Functional Concept]

Phrase: "of P-CREB levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   845   C1547597:Response level [Idea or Concept]
   795   C0441889:Levels [Qualitative Concept]
   785   C0428479:Protein level [Laboratory or Test Result]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1151818:P-protein [Molecular Function]
   710   C3158668:cAMP response element binding [Genetic Function]
   701   C1148749:P-element binding [Genetic Function]

Phrase: "(Fig. 1E"

Phrase: ")."
Processing 00000000.tx.101: After a 1-h treatment with 10M A-(1-42)(R) the estimates were, as a percentage of those in the untreated controls, 916.7% compared with less than 40% observed after exposure to 10M A-(1-42) (Fig. 1B). 

Phrase: "After a 1-h treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "with 10M A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(R)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "the estimates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:estimates [Quantitative Concept]

Phrase: "were"

Phrase: ","

Phrase: "as"

Phrase: "a percentage of those in the untreated controls,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0439165:Percentage [Quantitative Concept]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]

Phrase: "916.7%"

Phrase: "compared with less"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "than 40%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "observed after exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]
   790   C1441672:Observed [Functional Concept]

Phrase: "to 10M A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.102: None of the treatments had significant effects on total CREB levels (e.g. Fig. 1B). 

Phrase: "None of the treatments"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0087111:Treatments [Therapeutic or Preventive Procedure]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   737 E C0039798:treatment [Functional Concept]
   737 E C1522326:Treatment [Functional Concept]
   737 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   737 E C1705169:Treatment [Conceptual Entity]
   737 E C3538994:TREATMENT [Research Activity]

Phrase: "had"

Phrase: "significant effects on total CREB levels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "("

Phrase: "e.g. Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.103: We examined further CREB activation using immunocytochemistry and observed that membrane depolarization induced by exposure to elevated K+ resulted in almost all cells in a pronounced increase in P-CREB immunoreactivity, which was markedly attenuated by treatment with A-(1-42) (Fig. 2). 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "further CREB activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0599177:protein activation [Genetic Function]
   795   C1879547:Activation [Activity]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C3158668:cAMP response element binding [Genetic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunocytochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "and"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that membrane depolarization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1816453:membrane depolarization [Cell Function]

Phrase: "induced by exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205263:Induced [Functional Concept]
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]

Phrase: "to elevated K+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0856882:elevated k [Finding]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "resulted in almost"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "all cells in a pronounced increase"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in P-CREB immunoreactivity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0597879:immunoreactivity [Molecular Function]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1151818:P-protein [Molecular Function]
   710   C3158668:cAMP response element binding [Genetic Function]
   701   C1148749:P-element binding [Genetic Function]

Phrase: "which"

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "attenuated by treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C0332161:Attenuated [Qualitative Concept]
   790   C0599946:Attenuated [Activity]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.104: View larger version (44K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(44K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.105: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.106: Immunohistochemical analysis of CREB phosphorylated at Ser-133. 

Phrase: "Immunohistochemical analysis of CREB"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1514534:Protein Analysis [Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1441616:Immunohistochemical [Laboratory Procedure]
   744   C1524024:analysis [Functional Concept]
   703   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "phosphorylated at Ser-133."
Processing 00000000.tx.107: A, P-CREB immunoreactivity increased in cortical neuronal cultures exposed to 30mM KCl as compared with controls. 

Phrase: "A,"

Phrase: "P-CREB immunoreactivity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0597879:immunoreactivity [Molecular Function]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1151818:P-protein [Molecular Function]
   710   C3158668:cAMP response element binding [Genetic Function]
   701   C1148749:P-element binding [Genetic Function]

Phrase: "increased in cortical neuronal cultures"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0010453:Cultures [Idea or Concept]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0521390:Neuronal [Immunologic Factor]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]

Phrase: "exposed to 30mM KCl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0450396:30mm [Quantitative Concept]

Phrase: "as"

Phrase: "compared with controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.108: Treatment with 5M A-(1-42) for 1h suppressed the high K+-induced increase in P-CREB content. 

Phrase: "Treatment with 5M A-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "the high K+-induced increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:Increase [Functional Concept]

Phrase: "in P-CREB content."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   795   C0423896:Content [Mental Process]
   795   C0456205:Content [Conceptual Entity]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1151818:P-protein [Molecular Function]
   710   C3158668:cAMP response element binding [Genetic Function]
   701   C1148749:P-element binding [Genetic Function]
Processing 00000000.tx.109: B, quantification of P-CREB immunoreactivity. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantification of P-CREB immunoreactivity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1709793:Quantification [Quantitative Concept]
Processing 00000000.tx.110: C, control; 

Phrase: "C,"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.111: K, cultures treated with 30mM KCl; 

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "treated with 30mM KCl"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0450396:30mm [Quantitative Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: ";"
Processing 00000000.tx.112: K+A, high K+-treated cultures exposed to 5M A-(1-42). 

Phrase: "K+A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "high K+-treated cultures"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   886   C0680299:high culture [Population Group]
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "exposed to 5M A-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.113: Estimates represent the meanS.E. of three independent experiments. 

Phrase: "Estimates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:estimates [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanS.E."

Phrase: "of three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.114: Diffusible A-(1-42) Oligomers Decrease Neuronal Activity-induced Phosphorylation of CREB-- There is evidence that neurotoxicity in primary cultures is related to the ability of A-(1-42) to form fibrillary assemblies (3, 8, 26). 

Phrase: "Diffusible A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Oligomers"

Phrase: "Decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "Neuronal Activity-induced Phosphorylation of CREB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   739   C0031715:Phosphorylation [Molecular Function]

Phrase: "--"

Phrase: "There"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that neurotoxicity in primary cultures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "is"

Phrase: "related to the ability of A-"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0085732:Ability [Organism Attribute]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "fibrillary assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "8,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.115: In addition, A may form small diffusible oligomers (referred to as ADDLs, for A-derived diffusible ligands), which are highly neurotoxic (31, 32). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "small diffusible oligomers"

Phrase: "("

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to as ADDLs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1883351:To [Qualitative Concept]

Phrase: "for A-derived diffusible ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0023688:Ligands [Chemical]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "highly neurotoxic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.116: In the ADDL preparation used in the present study the formation of large A assemblies was reduced using clusterin, and the large assemblies that did form were removed by centrifugation, according to the procedure of Lambert et al. 

Phrase: "In the ADDL preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "used in the present study"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   781   C0869040:study use [Research Activity]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "the formation of large A assemblies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "clusterin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055966:Clusterin [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1413514:CLUSTERIN [Gene or Genome]

Phrase: "and"

Phrase: "the large assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "that"

Phrase: "did"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "removed by centrifugation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "according to the procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "of Lambert et al."
Processing 00000000.tx.117: (32) (see "Experimental Procedures"). 

Phrase: "(32"

Phrase: ")"

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.118: Most importantly, ADDLs cause degeneration of neurons at lower concentrations than conventionally assembled preparations (32) and may share properties with soluble A that is present in the AD brain. 

Phrase: "Most importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "ADDLs"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "degeneration of neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   790   C0011164:Degeneration [Pathologic Function]
   790   C1880269:Degeneration [Functional Concept]

Phrase: "at lower concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "than conventionally assembled preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]

Phrase: "(32"

Phrase: ")"

Phrase: "and"

Phrase: "may"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "properties with soluble A"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0871161:properties [Qualitative Concept]
   770   C1292721:properties [Functional Concept]
   737 E C1882134:Property [Conceptual Entity]
   737 E C2347695:Property [Entity]

Phrase: "that"

Phrase: "is"

Phrase: "present in the AD brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.119: Also under our experimental conditions, ADDLs compromised neuronal survival at concentrations lower than those needed to effect neurotoxicity with conventional fibrillar A-(1-42) preparations, causing significant cell loss (23%), already at a concentration of 1M after 24h of exposure. 

Phrase: "Also under our experimental conditions,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C1517586:Experimental [Qualitative Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
   704 E C0040607:Training [Educational Activity]
   704 E C0220931:Training [Educational Activity]
   704 E C0336809:Train [Manufactured Object]
   704 E C1552514:Train [Manufactured Object]
   704 E C2673163:training [Qualitative Concept]

Phrase: "ADDLs"

Phrase: "compromised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2945640:compromise [Finding]

Phrase: "neuronal survival at concentrations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1819944:neuron survival [Cell Function]
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]

Phrase: "lower than those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "needed to effect neurotoxicity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0235032:Neurotoxic effect [Injury or Poisoning]
           Neurotoxicity
   770   C0027552:Needed [Qualitative Concept]
   770   C0686904:needed [Functional Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "with conventional fibrillar A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "preparations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0455052:Preparation [Health Care Activity]
   966   C1521827:Preparation [Functional Concept]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "significant cell loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517945:Loss [Quantitative Concept]

Phrase: "(23%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "already at a concentration of 1M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0086045:Concentration [Mental Process]
   753   C0470296:1M [Quantitative Concept]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "after 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "of exposure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]
Processing 00000000.tx.120: Furthermore, at the sublethal concentrations of 100nM, ADDL elicited a marked suppression of the high K+-induced increase in P-CREB content to 6213.6% (n=3) of the levels in the untreated controls (Fig. 3). 

Phrase: "Furthermore,"

Phrase: "at the sublethal concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 100nM,"

Phrase: "ADDL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412232:ADDL [Gene or Genome]
  1000   C2698510:ADDL [Gene or Genome]

Phrase: "elicited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicited [Qualitative Concept]

Phrase: "a marked suppression of the high K+-induced increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0221103:Suppression [Pathologic Function]
   742   C0301625:Suppression [Organism Function]
   742   C0439181:% suppression [Quantitative Concept]
   742   C0728721:suppression [Mental Process]

Phrase: "in P-CREB content"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   795   C0423896:Content [Mental Process]
   795   C0456205:Content [Conceptual Entity]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1151818:P-protein [Molecular Function]
   710   C3158668:cAMP response element binding [Genetic Function]
   701   C1148749:P-element binding [Genetic Function]

Phrase: "to 6213.6%"

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "of the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the untreated controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0332155:untreated [Finding]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.121: View larger version (45K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(45K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.122: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.123: Treatment with ADDL (A-(1-42)-derived diffusible ligand) decreased high K+-induced CREB phosphorylation in cultured cortical neurons. 

Phrase: "Treatment with ADDL"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "(A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "derived diffusible ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023688:Ligand [Chemical]

Phrase: ")"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "high K+-induced CREB phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   807   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   791   C0031715:Phosphorylation [Molecular Function]
   707   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in cultured cortical neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.124: Western blot analysis of P-CREB: pretreatment with 100nM ADDL for 1h attenuated the elevation of P-CREB content induced by exposure of cortical neurons to 30mM KCl for 15min. 

Phrase: "Western blot analysis of P-CREB"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   782   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   760   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   757   C1514534:Protein Analysis [Molecular Biology Research Technique]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]
   739   C1705493:Western [Spatial Concept]

Phrase: ":"

Phrase: "pretreatment with 100nM ADDL"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "the elevation of P-CREB content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0439775:Elevation [Therapeutic or Preventive Procedure]
   739   C0702240:Elevation [Spatial Concept]

Phrase: "induced by exposure of cortical neurons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0001613:Cortical [Body Part, Organ, or Organ Component]
   753   C0007776:Cortical [Body Part, Organ, or Organ Component]
   753   C0022655:Cortical [Body Part, Organ, or Organ Component]
   753   C0027882:Neurons [Cell]
   753   C0205263:Induced [Functional Concept]
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]

Phrase: "to 30mM KCl"

Phrase: "for 15min."
Processing 00000000.tx.125: To determine whether the observed effects were specific to A-(1-42), the influence of A-(25-35), a toxic fragment of A, was examined. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the observed effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "specific to A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "the influence of A-"

Phrase: "(25-35"

Phrase: ")"

Phrase: ","

Phrase: "a toxic fragment of A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332255:fragment [Functional Concept]
   760   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.126: This fragment also elicited neuron loss at 25 M but, importantly, did not interfere with CREB phosphorylation at the sublethal concentration of 10M (Fig. 4, A and B). 

Phrase: "This fragment also elicited neuron loss at 25 M"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   764   C0598940:neuron loss [Finding]
   742   C1517945:Loss [Quantitative Concept]
   729 E C1850496:Neuronal loss [Finding]

Phrase: "but"

Phrase: ","

Phrase: "importantly,"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with CREB phosphorylation"
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   869   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C3158668:cAMP response element binding [Genetic Function]
   800   C1511573:cAMP Response Element [Gene or Genome]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   767 E C0033618:Protein Binding [Molecular Function]
   767   C1148918:cAMP binding [Molecular Function]
   744   C0013879:Element [Element, Ion, or Isotope]
   744   C0031715:Phosphorylation [Molecular Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   744   C0243122:binding [Functional Concept]
   744   C0521102:Interfere [Qualitative Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1704632:Response [Finding]
   744   C1705248:Element [Conceptual Entity]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "at the sublethal concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.127: Therefore, both the fibrillar A-(1-42) and the diffusible A-(1-42) oligomers (ADDLs) interfere at sublethal concentrations with neuronal activity-induced signal transduction via CREB, whereas the potent toxic fragment A-(25-35) is inactive. 

Phrase: "Therefore,"

Phrase: "both"

Phrase: "the fibrillar A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "the diffusible A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "oligomers"

Phrase: "(ADDLs"

Phrase: ")"

Phrase: "interfere at sublethal concentrations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0086045:Concentrations [Mental Process]
   770   C0521102:Interfere [Qualitative Concept]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "with neuronal activity-induced signal transduction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   911   C2756001:neuronal signal transduction [Cell Function]
   840   C0037083:Signal Transduction [Cell Function]
   804   C1160185:transduction [Organism Function]
   804   C1710082:Signal [Phenomenon or Process]

Phrase: "via CREB,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "whereas"

Phrase: "the potent toxic fragment A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "is"

Phrase: "inactive."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205254:Inactive [Qualitative Concept]
Processing 00000000.tx.128: View larger version (12K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.129: 4.  

Phrase: "4."
Processing 00000000.tx.130: Treatment with A-(1-42) but not A-(25-35), decreased high K+-induced CREB phosphorylation in cultured cortical neurons. 

Phrase: "Treatment with A-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "but"

Phrase: "not A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: ","

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "high K+-induced CREB phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   807   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   791   C0031715:Phosphorylation [Molecular Function]
   707   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in cultured cortical neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.131: A, Western blot analysis of P-CREB. 

Phrase: "A,"

Phrase: "Western blot analysis of P-CREB."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   782   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   760   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   757   C1514534:Protein Analysis [Molecular Biology Research Technique]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]
   739   C1705493:Western [Spatial Concept]
Processing 00000000.tx.132: In contrast to the marked suppression of the K+-induced increase of P-CREB levels by 5M A-(1-42), 1-h pretreatment with A-(25-35) at the sublethal concentration of 10M had no significant effect. 

Phrase: "In contrast to the marked suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0221103:Suppression [Pathologic Function]
   861   C0301625:Suppression [Organism Function]
   861   C0439181:% suppression [Quantitative Concept]
   861   C0728721:suppression [Mental Process]

Phrase: "of the K+-induced increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "of P-CREB levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   845   C1547597:Response level [Idea or Concept]
   795   C0441889:Levels [Qualitative Concept]
   785   C0428479:Protein level [Laboratory or Test Result]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1151818:P-protein [Molecular Function]
   710   C3158668:cAMP response element binding [Genetic Function]
   701   C1148749:P-element binding [Genetic Function]

Phrase: "by 5M A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "1-h pretreatment with A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1550147:Pretreatment [Substance]
   760   C2709094:pre treatment [Temporal Concept]
   760   C3539075:Pretreatment [Temporal Concept]
   760   C3539076:Pretreatment [Activity]

Phrase: "(25-35"

Phrase: ")"

Phrase: "at the sublethal concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: "had"

Phrase: "no significant effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.133: B, quantification of the effect of A-(25-35) (A25) versus A-(1-42) (A42) on the K+-induced increase of the level of P-CREB showed that significant suppression occurred after pretreatment with A-(1-42) (*, p<0.05), but not with A-(25-35) (n=3). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantification of the effect of A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709793:Quantification [Quantitative Concept]

Phrase: "(25-35"

Phrase: ")"

Phrase: "(A25"

Phrase: ")"

Phrase: "versus"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(A42"

Phrase: ")"

Phrase: "on the K+-induced increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "of the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of P-CREB"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   895   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   895   C1151818:P-protein [Molecular Function]
   885   C1148749:P-element binding [Genetic Function]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C0031705:P element [Element, Ion, or Isotope]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that significant suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0221103:Suppression [Pathologic Function]
   861   C0301625:Suppression [Organism Function]
   861   C0439181:% suppression [Quantitative Concept]
   861   C0728721:suppression [Mental Process]

Phrase: "occurred after pretreatment"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1550147:Pretreatment [Substance]
   790   C1709305:Occurred [Activity]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "with A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "("

Phrase: "*,"

Phrase: "p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not with A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1518422:Not [Functional Concept]

Phrase: "(25-35"

Phrase: ")"

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.134: Sublethal Concentrations of A-(1-42) Decrease NMDA Receptor-mediated CREB Activation-- CREB phosphorylation can also be elicited by nerve cell activation through the stimulation of NMDA receptors that play an important role in neuronal plasticity, including certain types of LTP (35, 36). 

Phrase: "Sublethal Concentrations of A-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "NMDA Receptor-mediated CREB Activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   879   C1514758:Receptor Activation [Cell Function]
   807   C0599177:protein activation [Genetic Function]
   791   C1879547:Activation [Activity]
   707   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   700   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "--"

Phrase: "CREB phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   799   C0031715:Phosphorylation [Molecular Function]
   780   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C3158668:cAMP response element binding [Genetic Function]

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "elicited by nerve cell activation"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   806   C0027882:Nerve cell [Cell]
   806   C0449265:Elicited by [Qualitative Concept]
           elicited
   806   C1326120:cell activation [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0027740:Nerve [Tissue]
   760   C0027757:NERVE [Tissue]
   760   C1269647:Cell [Cell]
   760   C1280541:Nerve [Body Part, Organ, or Organ Component]
   760   C1704653:Cell [Medical Device]
   760   C1879547:Activation [Activity]
   760   C1948049:Cell [Spatial Concept]
   704 E C0599851:Neural [Functional Concept]

Phrase: "through the stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "of NMDA receptors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0080093:NMDA Receptors [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1152805:NMDA receptor [Molecular Function]
   861   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "that"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in neuronal plasticity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "certain types of LTP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1710371:Term Type [Idea or Concept]
   753   C0332307:Types [Qualitative Concept]
   719 E C1547052:*Type [Quantitative Concept]

Phrase: "(35,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.135: A short exposure to NMDA in our cultures also evoked a marked increase in P-CREB levels, and this effect was suppressed by sublethal concentrations of A-(1-42) (Fig. 5). 

Phrase: "A short exposure to NMDA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332157:Exposure to [Clinical Attribute]
           Exposure
   760   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "in our cultures also"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "evoked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444748:Evoked [Qualitative Concept]

Phrase: "a marked increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in P-CREB levels,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   845   C1547597:Response level [Idea or Concept]
   795   C0441889:Levels [Qualitative Concept]
   785   C0428479:Protein level [Laboratory or Test Result]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1151818:P-protein [Molecular Function]
   710   C3158668:cAMP response element binding [Genetic Function]
   701   C1148749:P-element binding [Genetic Function]

Phrase: "and"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "suppressed by sublethal concentrations of A-"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0086045:Concentrations [Mental Process]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1260953:Suppressed [Functional Concept]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.136: As a percentage of P-CREB levels in the NMDA-treated cultures, pretreatment with 5M A-(1-42) reduced P-CREB levels to 597.2% (n=3). 

Phrase: "As a percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439165:Percentage [Quantitative Concept]
  1000   C1549488:Percentage [Idea or Concept]
  1000   C1561533:Percentage [Idea or Concept]

Phrase: "of P-CREB levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   845   C1547597:Response level [Idea or Concept]
   795   C0441889:Levels [Qualitative Concept]
   785   C0428479:Protein level [Laboratory or Test Result]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1151818:P-protein [Molecular Function]
   710   C3158668:cAMP response element binding [Genetic Function]
   701   C1148749:P-element binding [Genetic Function]

Phrase: "in the NMDA-treated cultures,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0010453:Cultures [Idea or Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "pretreatment with 5M A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "reduced P-CREB levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   834   C1547597:Response level [Idea or Concept]
   793   C0441889:Levels [Qualitative Concept]
   779   C0428479:Protein level [Laboratory or Test Result]
   760 E C0456079:Level [Classification]
   760 E C1547707:Level [Geographic Area]
   760 E C2946261:Level [Pharmacologic Substance]
   723   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to 597.2%"

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.137: None of the treatments had significant effects on total CREB levels (Fig. 5). 

Phrase: "None of the treatments"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0087111:Treatments [Therapeutic or Preventive Procedure]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   737 E C0039798:treatment [Functional Concept]
   737 E C1522326:Treatment [Functional Concept]
   737 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   737 E C1705169:Treatment [Conceptual Entity]
   737 E C3538994:TREATMENT [Research Activity]

Phrase: "had"

Phrase: "significant effects on total CREB levels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.138: View larger version (9K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.139: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.140: Treatment with A-(1-42) decreased NMDA-induced CREB phosphorylation in cultured cortical neurons. 

Phrase: "Treatment with A-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "decreased NMDA-induced CREB phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   807   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   791   C0031715:Phosphorylation [Molecular Function]
   707   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in cultured cortical neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.141: A, Western blot analysis of P-CREB. 

Phrase: "A,"

Phrase: "Western blot analysis of P-CREB."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   782   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   760   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   757   C1514534:Protein Analysis [Molecular Biology Research Technique]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]
   739   C1705493:Western [Spatial Concept]
Processing 00000000.tx.142: Pretreatment with 5M A-(1-42) for 1h attenuated the increase in P-CREB content evoked by exposure to 10M NMDA for 10min. 

Phrase: "Pretreatment with 5M A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "the increase in P-CREB content"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "evoked by exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]
   790   C1444748:Evoked [Qualitative Concept]

Phrase: "to 10M NMDA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "for 10min."
Processing 00000000.tx.143: Similar results were obtained in three independent experiments. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained in three independent experiments."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0085862:Independent [Idea or Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1299583:Independent [Finding]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.144: B, quantification of the effect of pretreatment with 5M A-(1-42) for 1h; 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantification of the effect of pretreatment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709793:Quantification [Quantitative Concept]

Phrase: "with 5M A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.145: estimates are expressed in terms of P-CREB levels obtained in the NMDA-exposed cultures and they are meanS.E. from three independent experiments. 

Phrase: "estimates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:estimates [Quantitative Concept]

Phrase: "are"

Phrase: "expressed in terms of P-CREB levels"
Meta Candidates (Total=27; Excluded=4; Pruned=0; Remaining=23)
   820   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C3158668:cAMP response element binding [Genetic Function]
   775   C1511573:cAMP Response Element [Gene or Genome]
   756   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   754 E C0033618:Protein Binding [Molecular Function]
   754   C1148918:cAMP binding [Molecular Function]
   738   C0013879:Element [Element, Ion, or Isotope]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   738   C0243122:binding [Functional Concept]
   738   C0441889:Levels [Qualitative Concept]
   738   C0871261:Response [Organism Attribute]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1704632:Response [Finding]
   738   C1705248:Element [Conceptual Entity]
   738   C1706817:Response [Intellectual Product]
   738   C2911692:Response [Mental Process]
   737   C1547597:Response level [Idea or Concept]
   722   C0428479:Protein level [Laboratory or Test Result]
   704 E C0456079:Level [Classification]
   704   C1515273:Term [Temporal Concept]
   704 E C1547707:Level [Geographic Area]
   704   C1705313:Term [Idea or Concept]
   704   C2826302:TERM [Intellectual Product]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "obtained in the NMDA-exposed cultures"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   753   C0010453:Cultures [Idea or Concept]
   753   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0332157:Exposed [Clinical Attribute]
   753   C1301820:Obtained [Functional Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C1706701:Obtain [Activity]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "they"

Phrase: "are"

Phrase: "meanS.E."

Phrase: "from three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.146: The effect of A-(1-42) was significant (*, p<0.05). 

Phrase: "The effect of A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "was"

Phrase: "significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "("

Phrase: "*,"

Phrase: "p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.147: Caspase Activation Does Not Contribute to the A-(1-42)-mediated Decrease in the Activity-induced Phosphorylation of CREB-- Although neurons remained viable in the presence of 1-10 M A-(1-42) during the experimental period, sublethal A-(1-42) may have triggered early apoptotic events that affect CREB signaling. 

Phrase: "Caspase Activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1159825:Caspase Activation [Molecular Function]
   861   C1879547:Activation [Activity]

Phrase: "Does"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Contribute to the A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1880177:Contribute [Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "mediated Decrease in the Activity-induced Phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "of CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "-"

Phrase: "-"

Phrase: "Although"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "remained"

Phrase: "viable in the presence of 1-10 M A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0443348:Viable [Qualitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "during the experimental period,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "sublethal A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "may"

Phrase: "have"

Phrase: "triggered"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "early apoptotic events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]

Phrase: "that"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "CREB signaling."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   895   C1155589:cAMP signaling [Molecular Function]
   799   C0037083:Signaling [Cell Function]
   799   C3537152:signaling [Biologic Function]
   780   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C3158668:cAMP response element binding [Genetic Function]
Processing 00000000.tx.148: Previous studies suggested that caspase activation plays an important role in A-(1-42)-induced apoptosis in neurons (37, 38). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that caspase activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1159825:Caspase Activation [Molecular Function]
   861   C1879547:Activation [Activity]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "induced apoptosis in neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C1660771:neuron apoptosis [Cell Function]
   783 E C1836846:Apoptotic neurons [Finding]
   770   C0162638:Apoptosis [Cell Function]

Phrase: "(37,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.149: We therefore blocked caspase activities, using the general inhibitor Z-VAD-fmk (39). 

Phrase: "We therefore blocked caspase activities,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   844   C1150130:caspase activity [Molecular Function]
   812   C0441655:Activities [Activity]
   779 E C0205177:Activity [Functional Concept]
   779 E C0439167:% activity [Quantitative Concept]
   779 E C1561536:*Activity [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the general inhibitor Z-VAD-fmk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0383779:Z-VAD-FMK [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0077973:VAD [Therapeutic or Preventive Procedure]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.150: The cultures in the presence and absence of A-(1-42) were exposed to Z-VAD-fmk under the conditions (150M, 1h of preincubation) when this compound is known to elicit effective caspase inhibition in cortical neurons and PC12 cells (40, 41). 

Phrase: "The cultures in the presence"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0010453:Cultures [Idea or Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "absence of A-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "were"

Phrase: "exposed to Z-VAD-fmk"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0383779:Z-VAD-FMK [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0077973:VAD [Therapeutic or Preventive Procedure]

Phrase: "under the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(150M,"

Phrase: "1h of preincubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442450:1H [Temporal Concept]

Phrase: ")"

Phrase: "when"

Phrase: "this compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205198:Compound [Qualitative Concept]
  1000   C1706082:Compound [Chemical]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "effective caspase inhibition in cortical neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
   742   C0234074:Neuronal inhibition [Organ or Tissue Function]

Phrase: "and"

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.151: The caspase inhibitor had no significant effect on either the basal or K+-induced phosphorylation of CREB and did not influence the A-(1-42)-induced suppression of high K+-activated CREB phosphorylation (Fig. 6). 

Phrase: "The caspase inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516312:Caspase Inhibitor [Pharmacologic Substance]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "had"

Phrase: "no significant effect on either"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "the basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "or"

Phrase: "K+-induced phosphorylation of CREB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   742   C0031715:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "the A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "induced suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0221103:Suppression [Pathologic Function]
   861   C0301625:Suppression [Organism Function]
   861   C0439181:% suppression [Quantitative Concept]
   861   C0728721:suppression [Mental Process]

Phrase: "of high K+-activated CREB phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   807   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   791   C0031715:Phosphorylation [Molecular Function]
   707   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.152: Thus sublethal A-(1-42) suppresses CREB signaling through a mechanism(s) independent of caspase activation. 

Phrase: "Thus sublethal A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "CREB signaling through a mechanism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1155589:cAMP signaling [Molecular Function]
   762   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0037083:Signaling [Cell Function]
   742   C3537152:signaling [Biologic Function]

Phrase: "("

Phrase: "s) independent of caspase activation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0332291:Independent of [Functional Concept]
   806   C1159825:Caspase Activation [Molecular Function]
   760   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]
   760   C1879547:Activation [Activity]
   760   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.153: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.154: 6.  

Phrase: "6."
Processing 00000000.tx.155: Z-VAD-fmk did not influence the effect of A-(1-42) in reducing the high K+-induced elevation of the P-CREB content. 

Phrase: "Z-VAD-fmk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0383779:Z-VAD-FMK [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0077973:VAD [Therapeutic or Preventive Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "the effect of A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "in reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the high K+-induced elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439775:Elevation [Therapeutic or Preventive Procedure]
   812   C0702240:Elevation [Spatial Concept]

Phrase: "of the P-CREB content."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   795   C0423896:Content [Mental Process]
   795   C0456205:Content [Conceptual Entity]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1151818:P-protein [Molecular Function]
   710   C3158668:cAMP response element binding [Genetic Function]
   701   C1148749:P-element binding [Genetic Function]
Processing 00000000.tx.156: Cultured cortical neurons at 5DIV were exposed to 10M A-(1-42) in the presence or absence of 150M Z-VAD-fmk for 1h, before treatment with 30mM KCl for 15min. 

Phrase: "Cultured cortical neurons at 5DIV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]

Phrase: "were"

Phrase: "exposed to 10M A-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1442446:10M [Temporal Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 150M Z-VAD-fmk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "for 1h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "before"

Phrase: "treatment with 30mM KCl"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "for 15min."
Processing 00000000.tx.157: The experiment was repeated with a similar outcome; 

Phrase: "The experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "repeated with a similar outcome"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0205341:Repeated [Functional Concept]
   760   C1274040:Outcome [Functional Concept]
   760   C2348205:Similar [Qualitative Concept]
   726 E C1547730:Repeat [Temporal Concept]
   726 E C1705914:Repeat [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.158: Z-VAD-fmk could not prevent the A-(1-42)-induced suppression of the neuronal activity-evoked elevation of P-CREB levels. 

Phrase: "Z-VAD-fmk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0383779:Z-VAD-FMK [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0077973:VAD [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "induced suppression of the neuronal activity-evoked elevation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0221103:Suppression [Pathologic Function]
   744   C0301625:Suppression [Organism Function]
   744   C0439181:% suppression [Quantitative Concept]
   744   C0728721:suppression [Mental Process]

Phrase: "of P-CREB levels."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   845   C1547597:Response level [Idea or Concept]
   795   C0441889:Levels [Qualitative Concept]
   785   C0428479:Protein level [Laboratory or Test Result]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1151818:P-protein [Molecular Function]
   710   C3158668:cAMP response element binding [Genetic Function]
   701   C1148749:P-element binding [Genetic Function]
Processing 00000000.tx.159: Low Concentrations of A-(1-42) Decrease CRE Transcriptional Activity and the Induction of BDNF Exon III-- To examine the consequences of the action of sublethal concentrations of A on CREB-mediated signal transduction, we analyzed the expression of one of the target genes of CREB, BDNF, which plays a critical role in neuronal survival, differentiation, and plasticity (20). 

Phrase: "Low Concentrations of A-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "CRE Transcriptional Activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C1511573:cAMP Response Element [Gene or Genome]

Phrase: "and"

Phrase: "the Induction of BDNF Exon III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205263:Induction [Functional Concept]
   742   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the consequences of the action of sublethal concentrations of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   743   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "on CREB-mediated signal transduction,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   906   C1155589:cAMP-mediated signal transduction [Molecular Function]
   812   C0037083:Signal Transduction [Cell Function]
   793   C1160185:transduction [Organism Function]
   793   C1710082:Signal [Phenomenon or Process]
   723   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the expression of one of the target genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0017262:Gene Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of CREB,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "BDNF,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "which"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a critical role in neuronal survival,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "plasticity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0678558:Plasticity [Natural Phenomenon or Process]
   928 E C0032167:Plastic [Substance]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.160: Previous studies showed that the BDNF gene gives rise to four primary transcripts through alternative splicing (42) and that the exon III containing mRNA is the most responsive to neuronal activity in the cerebral cortex and the hippocampus (17, 18). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the BDNF gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1332408:Brain-Derived Neurotrophic Factor Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   771   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise"

Phrase: "to four primary transcripts through alternative splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205225:Primary [Qualitative Concept]
   748   C0439631:Primary [Therapeutic or Preventive Procedure]
   748   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(42"

Phrase: ")"

Phrase: "and"

Phrase: "that"

Phrase: "the exon III containing mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "the most responsive to neuronal activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205342:Responsive [Functional Concept]

Phrase: "in the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.161: The effect is mediated largely by Ca2+ influx, and the promoter of exon III in the BDNF gene contains a CREB-response element (CRE) (17, 18). 

Phrase: "The effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "largely by Ca2+ influx,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "the promoter of exon III"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in the BDNF gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1332408:Brain-Derived Neurotrophic Factor Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   771   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a CREB-response element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C3158668:cAMP response element binding [Genetic Function]

Phrase: "(CRE"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1511573:cAMP Response Element [Gene or Genome]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: ")"

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.162: As an example of an important CREB-regulated gene, we examined the modulation by A-(1-42) of the activity-dependent expression of exon III-containing BDNF (exon III BDNF). 

Phrase: "As an example"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "of an important CREB-regulated gene,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   878   C1413106:CAMP gene [Gene or Genome]
   822   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0017337:Gene [Gene or Genome]
   723   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the modulation by A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443264:Modulation [Spatial Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "of the activity-dependent expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of exon III-containing BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   877   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   818   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   818   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   795   C0006104:Brain [Body Part, Organ, or Organ Component]
   795   C1269537:Brain [Body Part, Organ, or Organ Component]
   795   C1441547:Derived [Qualitative Concept]
   795   C1521761:Factor [Functional Concept]
   795   C2827422:Factor [Conceptual Entity]
   795   C3245521:derived [Idea or Concept]

Phrase: "(exon III BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   901   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   799   C0006104:Brain [Body Part, Organ, or Organ Component]
   799   C1269537:Brain [Body Part, Organ, or Organ Component]
   799   C1441547:Derived [Qualitative Concept]
   799   C1521761:Factor [Functional Concept]
   799   C2827422:Factor [Conceptual Entity]
   799   C3245521:derived [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.163: The activation of BDNF exon III promoter was monitored using a transient transcription activity assay with luciferase as a reporter gene. 

Phrase: "The activation of BDNF exon III promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a transient transcription activity assay with luciferase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C1151115:luciferase activity [Molecular Function]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0205177:Activity [Functional Concept]
   748   C0243073:assay [Qualitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "as a reporter gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206414:Reporter Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.164: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.165: 7A shows that K+-induced membrane depolarization increased exon III BDNF promoter activity 3-fold and A-(1-42) treatment ameliorated the induction by 31%. 

Phrase: "7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that K+-induced membrane depolarization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1816453:membrane depolarization [Cell Function]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "exon III BDNF promoter activity 3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332462:Fold [Spatial Concept]
   790   C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "ameliorated"

Phrase: "the induction by 31%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.166: We further examined the effect of A-(1-42) treatment on the expression of exon III BDNF, employing a quantitative RT-PCR as described previously (18). 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "treatment on the expression of exon III BDNF,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   754   C0679853:Treatment Factor [Intellectual Product]
   738   C0039798:treatment [Functional Concept]
   738   C0087111:Treatment [Therapeutic or Preventive Procedure]
   738   C1522326:Treatment [Functional Concept]
   738   C1533734:Treatment [Therapeutic or Preventive Procedure]
   738   C1705169:Treatment [Conceptual Entity]
   738   C3538994:TREATMENT [Research Activity]

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "a quantitative RT-PCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   901   C0599161:RT-PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0392762:Quantitative [Quantitative Concept]
   827   C0677874:pCR [Finding]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.167: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.168: 7, B and C, shows that exposure of cells to high K+ increased the expression of exon III BDNF by over 3-fold. 

Phrase: "7,"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that exposure of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]

Phrase: "to high K+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of exon III BDNF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by over 3-fold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.169: Treatment with A-(1-42) had no effect on the basal amount of mRNA (not shown) but decreased the membrane depolarization-elicited elevation of exon III BDNF expression to 38% of the control level. 

Phrase: "Treatment with A-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "had"

Phrase: "no effect on the basal amount of mRNA ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "but"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the membrane depolarization-elicited elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439775:Elevation [Therapeutic or Preventive Procedure]
   812   C0702240:Elevation [Spatial Concept]

Phrase: "of exon III BDNF expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0185117:Expression [Therapeutic or Preventive Procedure]
   710   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "to 38%"

Phrase: "of the control level."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0243148:control [Qualitative Concept]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2946261:Level [Pharmacologic Substance]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.170: View larger version (8K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(8K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.171: 7.  

Phrase: "7."
Processing 00000000.tx.172: Effect of A-(1-42) on BDNF exon III expression in cultured cortical neurons. 

Phrase: "Effect of A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "on BDNF exon III expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0185117:Expression [Therapeutic or Preventive Procedure]
   710   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "in cultured cortical neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.173: A, activity of the BDNF exon III promoter measured by the luciferase assay. 

Phrase: "A,"

Phrase: "activity of the BDNF exon III promoter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0443158:Brain activity [Physiologic Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "measured by the luciferase assay."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   760   C0243073:assay [Qualitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.174: Cortical neurons at 3DIV were transfected with plasmid pIII(170)Luc containing the promoter of BDNF exon III comprising the CRE-like sequence and exon III fused to a luciferase reporter gene. 

Phrase: "Cortical neurons at 3DIV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "were"

Phrase: "transfected with plasmid pIII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(170"

Phrase: ")"

Phrase: "Luc"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the promoter of BDNF exon III"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "comprising"

Phrase: "the CRE-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1511573:cAMP Response Element [Gene or Genome]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "like sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "exon III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "fused to a luciferase reporter gene."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0206414:Reporter Gene [Gene or Genome]
   783   C1334435:Luciferase Gene [Gene or Genome]
   767   C1414861:FUSE gene [Gene or Genome]
       E   FUSE
   753   C0017337:Gene [Gene or Genome]
   753   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   753   C0335038:Reporter [Professional or Occupational Group]
   753   C0699952:Fused [Functional Concept]
   753   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   753   C1705915:Reporter [Conceptual Entity]
   753   C1709908:Reporter [Group]
   719 E C1708111:Fuse [Manufactured Object]
Processing 00000000.tx.175: After 40h, cultures were switched to fresh medium and incubated for 1h in the presence or the absence of 5M A-(1-42), before the addition of a solution of KCl (final concentration 30mM) or vehicle and further incubation for 9h. 

Phrase: "After 40h,"

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "switched to fresh medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C0443224:Fresh [Qualitative Concept]
   770   C1705217:Medium [Substance]
   770   C2827486:Fresh [Body Substance]
   770   C3244283:medium [Intellectual Product]
   737   C1707719:Switch [Manufactured Object]

Phrase: "and"

Phrase: "incubated for 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442450:1H [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "the absence of 5M A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "before"

Phrase: "the addition of a solution of KCl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883712:Addition [Functional Concept]

Phrase: "(final concentration 30mM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450396:30mm [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "and"

Phrase: "further incubation for 9h."
Processing 00000000.tx.176: Transcription activity was assayed by measuring luciferase activity and expressed as the ratio of the luciferase activity in extracts from cells exposed to high K+ to the luciferase activity in extracts from unstimulated cell. 

Phrase: "Transcription activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "assayed by measuring luciferase activity"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   806   C1151115:luciferase activity [Molecular Function]
   760   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0444706:measuring [Qualitative Concept]
   760   C0449770:measuring [Quantitative Concept]
   760   C1561536:*Activity [Idea or Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "expressed as the ratio of the luciferase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1151115:luciferase activity [Molecular Function]
   744   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0456603:Ratio [Quantitative Concept]
   744   C1547037:Ratio [Intellectual Product]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "in extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "from cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to high K+"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0205250:High [Qualitative Concept]
   770   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1299351:High [Qualitative Concept]
   770   C1708601:K' [Quantitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "to the luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "in extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "from unstimulated cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.177: High K+ elicited the activation of BDNF exon III promoter (K). 

Phrase: "High K+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "elicited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicited [Qualitative Concept]

Phrase: "the activation of BDNF exon III promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1879547:Activation [Activity]

Phrase: "(K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.178: A-(1-42) treatment suppressed the high K+-induced activation of BDNF exon III promoter (K+A). 

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "the high K+-induced activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "of BDNF exon III promoter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   710   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(K+A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.179: Each value represents the meanS.D. of two independent experiments. 

Phrase: "Each value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanS.D."

Phrase: "of two independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.180: B, the expression of BDNF exon III gene and GAPDH gene (for normalization of the total RNA in the samples) was measured by RT-PCR. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the expression of BDNF exon III gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0017262:Gene Expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "GAPDH gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1414968:Glyceraldehyde-3-Phosphate Dehydrogenase Gene [Gene or Genome]
           GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE
   804   C0017337:Gene [Gene or Genome]
   771   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   722   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   717   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]

Phrase: "("

Phrase: "for normalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalization [Research Activity]

Phrase: "of the total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: "was"

Phrase: "measured by RT-PCR."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0444706:Measured [Qualitative Concept]
   770   C0677874:pCR [Finding]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.181: Total RNA (100ng) was reverse-transcribed into single-stranded cDNA, and the cDNA was amplified by PCR with exon-specific primers. 

Phrase: "Total RNA (100ng"

Phrase: ")"

Phrase: "was"

Phrase: "reverse-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed into single-stranded cDNA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1979975:Single strand [Qualitative Concept]
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]

Phrase: "and"

Phrase: "the cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "with exon-specific primers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.182: The PCR products were separated by electrophoresis on 6% polyacrylamide gels. 

Phrase: "The PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated by electrophoresis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "on 6% polyacrylamide gels."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   827   C0017243:Gels [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   793 E C1382104:Gel [Substance]
Processing 00000000.tx.183: C, quantification of RT-PCR products by PhosphorImager. 

Phrase: "C,"

Phrase: "quantification of RT-PCR products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantification [Quantitative Concept]

Phrase: "by PhosphorImager."
Processing 00000000.tx.184: The amount of total RNA in the samples was normalized to the amount of GAPDH. 

Phrase: "The amount of total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "in the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "normalized to the amount of GAPDH."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   818   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   818   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   784   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   742   C0017854:Glyceraldehyde [Carbohydrate]
   742   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   742   C0031701:phosphate [Organophosphorus Compound]
   742   C1265611:Amount [Quantitative Concept]
   742   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   742   C1882115:Normalized [Research Activity]
Processing 00000000.tx.185: Each value represents the meanS.E. from three independent experiments. 

Phrase: "Each value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanS.E."

Phrase: "from three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.186: Exon III BDNF mRNA levels were significantly increased in the high K+-exposed cells; 

Phrase: "Exon III BDNF mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   793   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0441889:Levels [Qualitative Concept]
   760 E C0456079:Level [Classification]
   760 E C1547707:Level [Geographic Area]
   760 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "increased in the high K+-exposed cells"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   774   C0022686:cells k [Cell]
   757 E C0022688:K cell [Cell]
   748   C0007634:Cells [Cell]
   748   C0205217:Increased [Quantitative Concept]
   748   C0205250:High [Qualitative Concept]
   748   C0332157:Exposed [Clinical Attribute]
   748   C0442805:Increased [Functional Concept]
   748   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1299351:High [Qualitative Concept]
   748   C1708601:K' [Quantitative Concept]
   748   C2700149:HIGH [Intellectual Product]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.187: pretreatment with 5M A-(1-42) significantly attenuated the high K+-induced elevation of exon III BDNF mRNA levels (p<0.05).  

Phrase: "pretreatment with 5M A-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "significantly"

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "the high K+-induced elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439775:Elevation [Therapeutic or Preventive Procedure]
   812   C0702240:Elevation [Spatial Concept]

Phrase: "of exon III BDNF mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   793   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0441889:Levels [Qualitative Concept]
   760 E C0456079:Level [Classification]
   760 E C1547707:Level [Geographic Area]
   760 E C2946261:Level [Pharmacologic Substance]

Phrase: "(p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.188: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES These observations provide the first evidence that sublethal levels of A-(1-42) interfere with gene expression regulated by activity-dependent signal transduction. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the first evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that sublethal levels of A-"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "interfere with gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0017262:Gene Expression [Genetic Function]
   770   C0017337:Gene [Gene or Genome]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0521102:Interfere [Qualitative Concept]

Phrase: "regulated by activity-dependent signal transduction."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0037083:Signal Transduction [Cell Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1160185:transduction [Organism Function]
   753   C1561536:*Activity [Idea or Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C1710082:Signal [Phenomenon or Process]
   753   C3244310:dependent [Functional Concept]
Processing 00000000.tx.189: Treatment of cortical neurons with concentrations of A-(1-42), which did not affect viability and had no apparent influence on the morphology of the cells, resulted in a marked suppression of activity-dependent stimulation of CREB and CREB/CRE-mediated gene transcription, assessed here by evaluating the expression of one of the CREB target genes, BDNF. 

Phrase: "Treatment of cortical neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:viability [Qualitative Concept]

Phrase: "and"

Phrase: "had"

Phrase: "no apparent influence on the morphology of the cells,"

Phrase: "resulted in a marked suppression of activity-dependent stimulation"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   742   C0205177:Activity [Functional Concept]
   742   C0221103:Suppression [Pathologic Function]
   742   C0301625:Suppression [Organism Function]
   742   C0439167:% activity [Quantitative Concept]
   742   C0439181:% suppression [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0522501:Marked [Qualitative Concept]
   742   C0728721:suppression [Mental Process]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   742   C1561536:*Activity [Idea or Concept]
   742   C1701901:Dependent [Qualitative Concept]
   742   C1706089:Marked [Qualitative Concept]
   742   C1948023:Stimulation [Natural Phenomenon or Process]
   742   C3244310:dependent [Functional Concept]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "of CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "CREB/CRE-mediated gene transcription,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   801   C0040649:Gene Transcription [Genetic Function]
           Transcription
   713   C1413106:CAMP gene [Gene or Genome]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "here by evaluating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0220825:Evaluate [Functional Concept]

Phrase: "the expression of one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of the CREB target genes,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C1413106:CAMP gene [Gene or Genome]
   813   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   801   C1332838:Target Gene [Gene or Genome]
   795   C0017337:Genes [Gene or Genome]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C3158668:cAMP response element binding [Genetic Function]

Phrase: "BDNF."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]
Processing 00000000.tx.190: Because of the critical role of CREB and BDNF in synaptic plasticity (13-15, 20), these observations suggest that low levels of A-(1-42) can engender a dysfunctional encoding state in neurons and may initiate early losses in cognitive function and/or contribute to the propagation of the cognitive deficit in later stage events of AD as A continues to accumulate. 

Phrase: "Because of the critical role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "of CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "BDNF in synaptic plasticity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   853   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1441547:Derived [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
   748   C3245521:derived [Idea or Concept]

Phrase: "(13-15,"

Phrase: "20"

Phrase: ")"

Phrase: ","

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that low levels of A-"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "can"

Phrase: "engender"

Phrase: "a dysfunctional encoding state in neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "may"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "early losses in cognitive function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1517945:Loss [Quantitative Concept]

Phrase: "and/or"

Phrase: "contribute to the propagation of the cognitive deficit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0679466:cognitive deficit [Mental or Behavioral Dysfunction]
   744   C0162429:Deficit, NOS [Disease or Syndrome]
   744   C1516691:Cognitive [Functional Concept]
   744   C1880177:Contribute [Activity]
   744   C2987487:Deficit [Qualitative Concept]

Phrase: "in later stage events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]
   717   C1279941:Late stage [Temporal Concept]

Phrase: "of AD"

Phrase: "as A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "continues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continue [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accumulate."
Processing 00000000.tx.191: In either case, the findings suggest that mechanisms other than neurodegeneration are contributing to losses in brain function. 

Phrase: "In either case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: "the findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that mechanisms other than neurodegeneration"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "contributing to losses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1880177:Contributing [Activity]
   756   C1517945:Loss [Quantitative Concept]

Phrase: "in brain function."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0678908:brain function [Organ or Tissue Function]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.192: Previous studies(e.g. 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "("

Phrase: "e.g."
Processing 00000000.tx.193: Refs. 

Phrase: "Refs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425988:REF [Gene or Genome]
Processing 00000000.tx.194: 1, 8, and 34), including from our own laboratory, have established that high levels of A-(1-42) result in neuronal cell death via apoptosis and secondary necrosis. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "8,"

Phrase: "and"

Phrase: "34"

Phrase: ")"

Phrase: ","

Phrase: "including from our own laboratory,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C0332257:Including [Functional Concept]
   760   C3244292:laboratory [Functional Concept]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]

Phrase: "have"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that high levels of A-"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "result in neuronal cell death"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   862   C2754100:neuronal cell death [Cell Function]
           neuron death
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1269647:Cell [Cell]
   760   C1274040:Result [Functional Concept]
   760   C1306577:Death, NOS [Finding]
   760   C1546471:Result [Idea or Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2825142:Result [Finding]

Phrase: "via apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "secondary necrosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027540:Necrosis [Organ or Tissue Function]
   861   C1334928:Necrosis [Finding]
Processing 00000000.tx.195: Recent studies (9-11) on transgenic mice overexpressing FAD mutant APPs (1, 4, 5) and observations on AD subjects are consistent with the view that cognitive decline might occur prior to pronounced accumulation of A and before widespread neuronal degeneration takes place in the brain. 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(9-11"

Phrase: ")"

Phrase: "on transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "FAD mutant APPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C3538722:APP [Laboratory Procedure]
   717   C0276496:Alzheimer disease, familial [Disease or Syndrome]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "observations on AD subjects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0302523:observations [Research Activity]
   770   C0700325:observations [Health Care Activity]
   770   C3244290:observations [Functional Concept]
   737 E C1964257:Observation [Diagnostic Procedure]

Phrase: "are"

Phrase: "consistent with the view"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "might"

Phrase: "occur prior to pronounced accumulation of A"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0332152:Prior to [Temporal Concept]
           Prior
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]
   748   C2826257:PRIOR [Event]

Phrase: "and"

Phrase: "before widespread neuronal degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   825   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   812   C0011164:Degeneration [Pathologic Function]
   812   C1880269:Degeneration [Functional Concept]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place in the brain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442504:Place [Spatial Concept]
   770   C1704765:Place [Functional Concept]
   770   C1882509:Place [Activity]
   770   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.196: Animals overexpressing the FAD mutant APP develop progressively histopathological abnormalities including typical neuritic amyloid plaques and dystrophic neurites, but loss of neurons is not a consistent feature and may relate to the genetic background of the animals rather than to the phenotype (4, 7, 43). 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "the FAD mutant APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3538722:APP [Laboratory Procedure]
   717   C0276496:Alzheimer disease, familial [Disease or Syndrome]

Phrase: "develop"

Phrase: "progressively histopathological abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "typical neuritic amyloid plaques"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   875   C0333463:Neuritic Plaques [Acquired Abnormality]
           amyloid plaques
           plaques
   861   C2936349:Plaques, Amyloid [Acquired Abnormality]
   779 E C0011389:Plaque [Disease or Syndrome]
   779 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "dystrophic neurites,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2674684:Dystrophic neurites [Finding]
   861   C0085103:Neurites [Cell Component]

Phrase: "but"

Phrase: "loss of neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0598940:Loss of neurons [Finding]
           neuron loss
   816 E C1850496:Neuronal loss [Finding]
   790   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a consistent feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1521970:Feature [Qualitative Concept]
   861   C1706388:Feature [Conceptual Entity]
   861   C2346469:Feature [Qualitative Concept]
   861   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "may"

Phrase: "relate to the genetic background of the animals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0003062:Animals [Animal]
   744   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   744   C0163712:Relate [Organic Chemical]
   744   C0314603:Genetic [Functional Concept]
   744   C1706907:Background [Conceptual Entity]
   722   C3494749:Animal - origin [Finding]

Phrase: "rather than to the phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031437:Phenotype [Organism Attribute]
   760   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(4,"

Phrase: "7,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.197: The mice show functional deficits affecting synaptic plasticity, and the performance of the aged transgenics in spatial working memory tasks is impaired (4). 

Phrase: "The mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "functional deficits"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "synaptic plasticity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0032167:Plastic [Substance]

Phrase: "and"

Phrase: "the performance of the aged transgenics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0597198:Performance [Individual Behavior]
   753   C1882330:Performance [Activity]

Phrase: "in spatial working memory tasks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C3540678:Task [Occupational Activity]
   708   C0814087:spatial memory [Mental Process]

Phrase: "is"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.198: In view of our findings, it is particularly important that in transgenic animals, which were generated in order to increase A levels in the context of relatively low APP expression (Swedish/Indiana double mutations in APP), deficit in long term potentiation was already observed at a relatively young age when amyloid plaques are not yet apparent but an increase in A expression is detectable (5). 

Phrase: "In view of our findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "it"

Phrase: "is"

Phrase: "particularly important"

Phrase: "that in transgenic animals,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0003069:Animals, Transgenic [Animal]
           Transgenic
   770   C0003062:Animals [Animal]

Phrase: "which"

Phrase: "were"

Phrase: "generated in order to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1705175:Order [Intellectual Product]
   770   C1705176:Order [Qualitative Concept]
   770   C1705177:Order [Classification]
   770   C1705178:Order [Activity]
   770   C1882348:Order [Qualitative Concept]
   770   C3146294:Generated [Activity]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "A levels in the context of relatively low APP expression"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   741   C3244092:expression level [Idea or Concept]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Swedish/Indiana double mutations in APP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: ","

Phrase: "deficit in long term potentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0162429:Deficit, NOS [Disease or Syndrome]
   760   C2987487:Deficit [Qualitative Concept]

Phrase: "was"

Phrase: "already"

Phrase: "observed at a relatively young age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0332239:Young [Temporal Concept]
   753   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "are"

Phrase: "not yet apparent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0750489:apparent [Idea or Concept]

Phrase: "but"

Phrase: "an increase in A expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "detectable"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.199: Recent observations have shown that soluble intermediate forms of A assemblies, such as A protofilaments (44) and ADDLs (32), can interfere with neuronal function and survival irrespective of the formation of mature A fibrils. 

Phrase: "Recent observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that soluble intermediate forms of A assemblies,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "such as A protofilaments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1179914:Protofilament [Cell Component]

Phrase: "(44"

Phrase: ")"

Phrase: "and"

Phrase: "ADDLs"

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "can"

Phrase: "interfere with neuronal function"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0031843:function [Physiologic Function]
   770   C0521102:Interfere [Qualitative Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "survival irrespective of the formation of mature A fibrils."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0038952:Survival [Activity]
   742   C0220921:survival [Functional Concept]
Processing 00000000.tx.200: Our findings are in agreement with these results. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1551058:Are [Quantitative Concept]

Phrase: "with these results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.201: ADDLs compromised neuron survival, and at sublethal levels reduced the activity-dependent signaling via CREB at lower concentrations than fully fibrillar A, consistent with a role of the peptide in disrupting neuronal function during the development of AD. 

Phrase: "ADDLs"

Phrase: "compromised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2945640:compromise [Finding]

Phrase: "neuron survival,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1819944:neuron survival [Cell Function]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "and at sublethal levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0441889:Levels [Qualitative Concept]
   770   C1515981:And [Idea or Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the activity-dependent signaling via CREB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1155589:cAMP signaling [Molecular Function]
   757   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0037083:Signaling [Cell Function]
   739   C3537152:signaling [Biologic Function]

Phrase: "at lower concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "than fully fibrillar A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "consistent with a role of the peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in disrupting neuronal function"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0031843:function [Physiologic Function]
   827   C0521390:Neuronal [Immunologic Factor]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0027882:Neuron [Cell]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "during the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of AD."
Processing 00000000.tx.202: That low levels of A-(1-42) may compromise brain functions through mechanisms unrelated to degenerative changes was supported by our observation that A-(25-35) at sublethal concentration did not interfere with activity-dependent signal transduction and that caspase inhibitors, which are known to prevent A-(1-42)-induced apoptosis, failed to counteract the A-(1-42)-evoked suppression of CREB activation. 

Phrase: "That low levels of A-"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "may"

Phrase: "compromise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "brain functions through mechanisms"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0678908:brain functions [Organ or Tissue Function]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0542341:Functions [Functional Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]

Phrase: "unrelated to degenerative changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0445356:Unrelated [Finding]
   770   C1704623:Unrelated [Qualitative Concept]

Phrase: "was"

Phrase: "supported by our observation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1521721:Supported [Conceptual Entity]
   770   C1964257:Observation [Diagnostic Procedure]
   737 E C0183683:Support [Medical Device]

Phrase: "that A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "at sublethal concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with activity-dependent signal transduction"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0037083:Signal Transduction [Cell Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0521102:Interfere [Qualitative Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1160185:transduction [Organism Function]
   753   C1561536:*Activity [Idea or Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C1710082:Signal [Phenomenon or Process]
   753   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "that caspase inhibitors,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1516312:Caspase Inhibitors [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "induced apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "counteract"

Phrase: "the A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "evoked suppression of CREB activation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0221103:Suppression [Pathologic Function]
   742   C0301625:Suppression [Organism Function]
   742   C0439181:% suppression [Quantitative Concept]
   742   C0728721:suppression [Mental Process]
Processing 00000000.tx.203: CREB/CRE is known to play a central and highly conserved role in the molecular mechanisms underlying synaptic plasticity, including learning and memory (13-15). 

Phrase: "CREB/CRE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   723   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a central"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205099:Central [Spatial Concept]
  1000   C1879652:Central - [Laboratory Procedure]

Phrase: "and"

Phrase: "highly conserved role in the molecular mechanisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "underlying"

Phrase: "synaptic plasticity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0032167:Plastic [Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "(13-15"

Phrase: ")."
Processing 00000000.tx.204: As cognitive deficit is central to the pathophysiology of AD, it is relevant that a reduction of P-CREB levels has been observed in the postmortem AD brain (45). 

Phrase: "As cognitive deficit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0679466:cognitive deficit [Mental or Behavioral Dysfunction]
   861   C0162429:Deficit, NOS [Disease or Syndrome]
   861   C2987487:Deficit [Qualitative Concept]

Phrase: "is"

Phrase: "central to the pathophysiology of AD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205099:Central [Spatial Concept]
   753   C1879652:Central - [Laboratory Procedure]

Phrase: "it"

Phrase: "is"

Phrase: "relevant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347946:Relevant [Qualitative Concept]

Phrase: "that"

Phrase: "a reduction of P-CREB levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0301630:Reduction [Natural Phenomenon or Process]
   739   C0392756:Reduction [Qualitative Concept]
   739   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "observed in the postmortem AD brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0004398:postmortem [Diagnostic Procedure]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0580205:Postmortem [Temporal Concept]
   753   C0848632:post mortem [Finding]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1441672:Observed [Functional Concept]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.205: Our observations that neuronal activity-induced CREB phosphorylation is suppressed by sublethal levels of A-(1-42) are consistent with these findings. 

Phrase: "Our observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that neuronal activity-induced CREB phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   807   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   791   C0031715:Phosphorylation [Molecular Function]
   707   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "suppressed by sublethal levels of A-"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0441889:Levels [Qualitative Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1260953:Suppressed [Functional Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "are"

Phrase: "consistent with these findings."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   767   C0332529:Consistency finding [Qualitative Concept]
Processing 00000000.tx.206: It has been reported, however, that in certain non-neuronal cells A can increase CREB phosphorylation. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "however,"

Phrase: "that in certain non-neuronal cells A"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   802   C0027836:Non-neuronal cell [Cell]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0007634:Cells [Cell]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0521390:Neuronal [Immunologic Factor]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1518422:Non [Functional Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "CREB phosphorylation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   799   C0031715:Phosphorylation [Molecular Function]
   780   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C3158668:cAMP response element binding [Genetic Function]
Processing 00000000.tx.207: Thus in undifferentiated PC12 cells A-(1-40) can lead to CREB activation (46), and in cultures of primary microglia and THP1 monocytes, relatively high concentration of fibrillar A-(25-35) (50M) has a similar effect (47). 

Phrase: "Thus in undifferentiated PC12 cells A-"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C0085262:PC12 Cells [Cell]
           PC-12
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007634:Cells [Cell]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0205618:Undifferentiated [Qualitative Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   753   C1524083:Undifferentiated [Organism Attribute]
   753   C1704620:Undifferentiated [Organism Attribute]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "can"

Phrase: "lead to CREB activation"
Meta Candidates (Total=26; Excluded=1; Pruned=0; Remaining=25)
   869   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C3158668:cAMP response element binding [Genetic Function]
   800   C1511573:cAMP Response Element [Gene or Genome]
   793   C1657589:response to cAMP [Cell Function]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0599177:protein activation [Genetic Function]
   770   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   767 E C0033618:Protein Binding [Molecular Function]
   767   C1148918:cAMP binding [Molecular Function]
   744   C0013879:Element [Element, Ion, or Isotope]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   744   C0243122:binding [Functional Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1704632:Response [Finding]
   744   C1705248:Element [Conceptual Entity]
   744   C1706817:Response [Intellectual Product]
   744   C1879547:Activation [Activity]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C2911692:Response [Mental Process]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(46"

Phrase: ")"

Phrase: ","

Phrase: "and in cultures of primary microglia"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0010453:Cultures [Idea or Concept]
   753   C0205225:Primary [Qualitative Concept]
   753   C0206116:Microglia [Cell]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C1515981:And [Idea or Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "THP1 monocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026473:Monocytes [Cell]

Phrase: "relatively high concentration of fibrillar A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "(25-35"

Phrase: ")"

Phrase: "(50M"

Phrase: ")"

Phrase: "has"

Phrase: "a similar effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.208: Responses of these cells to A are markedly different from those observed in nerve cells. 

Phrase: "Responses of these cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "to A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "markedly different from those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "observed in nerve cells."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C0027882:Nerve Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0027740:Nerve [Tissue]
   770   C0027757:NERVE [Tissue]
   770   C1280541:Nerve [Body Part, Organ, or Organ Component]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   715 E C0599851:Neural [Functional Concept]
Processing 00000000.tx.209: In contrast to these non-neuronal cells, our data show that A-(1-42) had no significant effect on CREB phosphorylation in resting neurons. 

Phrase: "In contrast to these non-neuronal cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "had"

Phrase: "no significant effect on CREB phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1301751:No effect [Qualitative Concept]
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "in resting neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.210: Furthermore, in contrast to A-(1-42), A-(25-35) had no significant influence on high K+-induced activation of CREB. 

Phrase: "Furthermore,"

Phrase: "in contrast to A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25-35"

Phrase: ")"

Phrase: "had"

Phrase: "no significant influence on high K+-induced activation"

Phrase: "of CREB."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]
Processing 00000000.tx.211: The careful study of McDonald et al. 

Phrase: "The careful study of McDonald et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]
Processing 00000000.tx.212: (47) elucidated that the signal transduction mechanisms leading to 50M A-(25-35)-induced CREB phosphorylation in microglia and monocytes involve protein tyrosine kinase-dependent activation of two parallel pathways, extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. 

Phrase: "(47"

Phrase: ")"

Phrase: "elucidated"

Phrase: "that"

Phrase: "the signal transduction mechanisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]
   734   C0037083:Signal Transduction [Cell Function]

Phrase: "leading to 50M A-"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0332152:Leading [Temporal Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(25-35"

Phrase: ")-"

Phrase: "induced CREB phosphorylation in microglia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   742   C0031715:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "monocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026473:Monocytes [Cell]

Phrase: "involve"

Phrase: "protein tyrosine kinase-dependent activation of two parallel pathways,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C1819041:protein kinase activation [Cell Function]
   770   C1514528:Protein Activation Pathway [Functional Concept]
   770   C3156336:protein activation pathway [Molecular Function]
   762   C0599177:protein activation [Genetic Function]
   742   C1879547:Activation [Activity]

Phrase: "extracellular signal-regulated kinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   979   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   979   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0521119:Extracellular [Cell Component]
   812   C0851285:Regulated [Governmental or Regulatory Activity]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "p38 mitogen-activated protein kinases."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   966 E C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C0752312:Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.213: On the other hand, in nerve cells the depolarization-induced phosphorylation of CREB is primarily dependent on Ca2+ influx-mediated activation of Ca2+-calmodulin-dependent protein kinase IV. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "in nerve cells"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0027882:Nerve Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]

Phrase: "the depolarization-induced phosphorylation of CREB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   739   C0031715:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "primarily dependent on Ca2+ influx-mediated activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "of Ca2+-calmodulin-dependent protein kinase IV."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   947   C0081889:Calmodulin-Dependent Protein Kinase IV [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0769224:calmodulin dependent protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   713 E C0006776:Calmodulin-Dependent Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.214: This has been demonstrated previously (17) and confirmed in our studies by the pronounced inhibition of the high K+-induced CREB phosphorylation by the Ca2+-calmodulin-dependent protein kinase inhibitor KN62 (not shown). 

Phrase: "This"

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "previously"

Phrase: "(17"

Phrase: ")"

Phrase: "and"

Phrase: "confirmed in our studies"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0521093:confirmed [Qualitative Concept]
   770   C0750484:Confirmed [Idea or Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C1456348:Confirm [Qualitative Concept]
   737 E C2603343:Study [Research Activity]

Phrase: "by the pronounced inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of the high K+-induced CREB phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   807   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   791   C0031715:Phosphorylation [Molecular Function]
   707   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by the Ca2+-calmodulin-dependent protein kinase inhibitor KN62"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   710   C0769224:calmodulin dependent protein kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.215: The transfection of three familial APP mutations (V642I, V642F, and V642G) in neurons resulted in suppressed transcriptional activity of CRE (48). 

Phrase: "The transfection of three familial APP mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "(V642I,"

Phrase: "V642F,"

Phrase: "and"

Phrase: "V642G"

Phrase: ")"

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "resulted in suppressed transcriptional activity of CRE"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   790   C1511573:cAMP Response Element [Gene or Genome]
   764   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0013879:Element [Element, Ion, or Isotope]
   742   C0040649:Transcriptional [Genetic Function]
   742   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0871261:Response [Organism Attribute]
   742   C1260953:Suppressed [Functional Concept]
   742   C1561536:*Activity [Idea or Concept]
   742   C1704632:Response [Finding]
   742   C1705248:Element [Conceptual Entity]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.216: Interference with events downstream of activated CREB was supported by the finding that sublethal A-(1-42) suppressed the neuronal activity-dependent transcription of the exon III-containing BDNF. 

Phrase: "Interference with events"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0521102:Interference [Qualitative Concept]

Phrase: "downstream of activated CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "supported by the finding"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C1521721:Supported [Conceptual Entity]
   770   C2825141:Finding [Finding]
   737 E C0183683:Support [Medical Device]

Phrase: "that sublethal A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "the neuronal activity-dependent transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0040649:Transcription [Genetic Function]

Phrase: "of the exon III-containing BDNF."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   877   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   818   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   818   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   795   C0006104:Brain [Body Part, Organ, or Organ Component]
   795   C1269537:Brain [Body Part, Organ, or Organ Component]
   795   C1441547:Derived [Qualitative Concept]
   795   C1521761:Factor [Functional Concept]
   795   C2827422:Factor [Conceptual Entity]
   795   C3245521:derived [Idea or Concept]
Processing 00000000.tx.217: BDNF is a complex gene that contains five exons (42). 

Phrase: "BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "is"

Phrase: "a complex gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "five exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.218: The coding region is entirely in exon V, whereas each of the first four exons has a unique promoter, containing different regulatory elements on the 5'-flanking region. 

Phrase: "The coding region"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0079941:Coding Region [Gene or Genome]
   861   C0009219:Coding [Occupational Activity]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   827 E C0805701:Code [Intellectual Product]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "entirely in exon V,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "whereas"

Phrase: "each of the first four exons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205435:First [Quantitative Concept]
   753   C0205450:Four [Quantitative Concept]
   753   C1279901:First [Qualitative Concept]
   753   C1457900:Each [Quantitative Concept]

Phrase: "has"

Phrase: "a unique promoter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "different regulatory elements on the 5'-flanking region."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   767   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
           Regulatory Element
   744   C0013879:Elements [Element, Ion, or Isotope]
   744   C0220905:regulatory [Regulation or Law]
   744   C1704735:Regulatory [Conceptual Entity]
   711 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.219: Each of the four 5' exons is, therefore, differentially regulated and gives rise to four primary BDNF transcripts. 

Phrase: "Each of the four 5' exons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205450:Four [Quantitative Concept]
   753   C1457900:Each [Quantitative Concept]

Phrase: "is"

Phrase: ","

Phrase: "therefore,"

Phrase: "differentially"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise"

Phrase: "to four primary BDNF transcripts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.220: The promoter of exon III contains a CRE and a response element to a novel Ca2+-regulated factor (17, 18); 

Phrase: "The promoter of exon III"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a CRE"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1511573:cAMP Response Element [Gene or Genome]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "a response element to a novel Ca2+-regulated factor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0013879:Element [Element, Ion, or Isotope]
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1705248:Element [Conceptual Entity]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: "(17,"

Phrase: "18"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.221: thus BDNF is a CREB target gene. 

Phrase: "thus BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   937   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C3245521:derived [Idea or Concept]

Phrase: "is"

Phrase: "a CREB target gene."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   893   C1413106:CAMP gene [Gene or Genome]
   829   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1332838:Target Gene [Gene or Genome]
   795   C0017337:Gene [Gene or Genome]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C3158668:cAMP response element binding [Genetic Function]
Processing 00000000.tx.222: The relevance of sublethal A-(1-42)-induced suppression of the neuronal activity-dependent phosphorylation of CREB and the induction of the CREB target gene BDNF is underlined by the observation that the content of both the BDNF transcript and protein is markedly reduced in brain regions, such as the hippocampus, which are severely affected in AD (23-25). 

Phrase: "The relevance of sublethal A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevance [Qualitative Concept]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "induced suppression of the neuronal activity-dependent phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0221103:Suppression [Pathologic Function]
   744   C0301625:Suppression [Organism Function]
   744   C0439181:% suppression [Quantitative Concept]
   744   C0728721:suppression [Mental Process]

Phrase: "of CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "the induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of the CREB target gene BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   832   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   832   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   801   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   801   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   801   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   788   C0006104:Brain [Body Part, Organ, or Organ Component]
   788   C1269537:Brain [Body Part, Organ, or Organ Component]
   788   C1441547:Derived [Qualitative Concept]
   788   C1521761:Factor [Functional Concept]
   788   C2827422:Factor [Conceptual Entity]
   788   C3245521:derived [Idea or Concept]

Phrase: "is"

Phrase: "underlined by the observation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]

Phrase: "that"

Phrase: "the content of both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]

Phrase: "the BDNF transcript"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "reduced in brain regions,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1273723:brain regions [Body Location or Region]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0392756:Reduced [Qualitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "such as the hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "which"

Phrase: "are"

Phrase: "severely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205082:Severely [Qualitative Concept]

Phrase: "affected in AD (23-25"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0392760:Affected [Functional Concept]
   760   C0450348:23 [Quantitative Concept]
   760   C1314939:Affected [Functional Concept]
   726 E C0001721:Affect [Mental Process]

Phrase: ")."
Processing 00000000.tx.223: Because of the role of CREB and BDNF in neuronal plasticity, including learning and memory (20, 21), the reduction may contribute to the cognitive deficit in AD. 

Phrase: "Because of the role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "of CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "BDNF in neuronal plasticity,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   853   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   816   C1826397:NEURON-DERIVED NEUROTROPHIC FACTOR [Gene or Genome]
   816   C3472710:neuron-derived neurotrophic factor [Gene or Genome]
   778   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1441547:Derived [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
   748   C3245521:derived [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "(20,"

Phrase: "21"

Phrase: ")"

Phrase: ","

Phrase: "the reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "contribute to the cognitive deficit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0679466:cognitive deficit [Mental or Behavioral Dysfunction]
   760   C0162429:Deficit, NOS [Disease or Syndrome]
   760   C1516691:Cognitive [Functional Concept]
   760   C1880177:Contribute [Activity]
   760   C2987487:Deficit [Qualitative Concept]

Phrase: "in AD."
Processing 00000000.tx.224: Although the BDNF protein is not the exclusive product of the exon III-containing transcript, our finding that sublethal levels of A-(1-42) result in the suppression of the activity-dependent phosphorylation of CREB and the consecutive expression of BDNF indicates that the peptide may interfere with neuronal functions early in the course of the disease, preceding the stage when massive neuronal degeneration is evident.  

Phrase: "Although"

Phrase: "the BDNF protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0027754:Neurotrophic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the exclusive product of the exon III-containing transcript,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1514468:product [Entity]
   742   C1704444:Product [Quantitative Concept]

Phrase: "our"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that sublethal levels of A-"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "result in the suppression of the activity-dependent phosphorylation"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0221103:Suppression [Pathologic Function]
   742   C0301625:Suppression [Organism Function]
   742   C0439167:% activity [Quantitative Concept]
   742   C0439181:% suppression [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0728721:suppression [Mental Process]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1158886:Phosphorylation [Molecular Function]
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C1561536:*Activity [Idea or Concept]
   742   C1701901:Dependent [Qualitative Concept]
   742   C2825142:Result [Finding]
   742   C3244310:dependent [Functional Concept]

Phrase: "of CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "the consecutive expression of BDNF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "indicates"

Phrase: "that"

Phrase: "the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "may"

Phrase: "interfere with neuronal functions early"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0521102:Interfere [Qualitative Concept]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C0542341:Functions [Functional Concept]
   760   C1279919:Early [Temporal Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]

Phrase: "in the course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "of the disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "preceding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:Preceding [Temporal Concept]

Phrase: "the stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "when"

Phrase: "massive neuronal degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   865   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   827   C0011164:Degeneration [Pathologic Function]
   827   C1880269:Degeneration [Functional Concept]

Phrase: "is"

Phrase: "evident."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.225: ACKNOWLEDGEMENT We thank Dr. 

Phrase: "ACKNOWLEDGEMENT"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.226: Michael E.

Phrase: "Michael E."
Processing 00000000.tx.227: Greenberg for plasmid pIII(170)Luc.  

Phrase: "Greenberg for plasmid pIII"

Phrase: "(170"

Phrase: ")"

Phrase: "Luc."
Processing 00000000.tx.228: FOOTNOTES * This work was supported by National Institutes of Health Grant RO1-NS-40953.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Institutes of Health Grant RO1-NS-40953."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   739   C0018173:Grant [Quantitative Concept]
   739   C0018684:Health [Idea or Concept]
   739   C0021622:Institutes [Organization]
   739   C1521721:Supported [Conceptual Entity]
   739   C1548284:Grant [Idea or Concept]
   739   C3245503:national [Intellectual Product]
   706 E C0183683:Support [Medical Device]
   706 E C1272753:Institute [Idea or Concept]
Processing 00000000.tx.229: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.230: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.231: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.232: To whom correspondence should be addressed: Institute for Brain Aging and Dementia, University of California, Irvine, CA 92697-4540.Tel.: 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Institute for Brain Aging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "University of California,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006754:California [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C3146274:California [Plant]

Phrase: "Irvine,"

Phrase: "CA 92697-4540.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0796520:TEL [Gene or Genome]
   812   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.233: 949-824-6071; 

Phrase: "949-824-6071"

Phrase: ";"
Processing 00000000.tx.234: Fax: 949-824-2071; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "949-824-2071"

Phrase: ";"
Processing 00000000.tx.235: E-mail: tongl@uci.edu. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "tongl@uci.edu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.236: Published, JBC Papers in Press, February 26,2001,DOI 10.1074/jbc.M010450200  ABBREVIATIONS The abbreviations used are: AD, Alzheimer's disease; 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "February 26,"

Phrase: "2001,"

Phrase: "DOI 10.1074/jbc.M010450200  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.237: A, -amyloid; 

Phrase: "A, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.238: ADDL, A-derived diffusible ligands; 

Phrase: "ADDL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412232:ADDL [Gene or Genome]
  1000   C2698510:ADDL [Gene or Genome]

Phrase: "A-derived diffusible ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0023688:Ligands [Chemical]

Phrase: ";"
Processing 00000000.tx.239: APP, amyloid precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.240: BDNF, brain-derived neurotrophic factor; 

Phrase: "BDNF,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "brain-derived neurotrophic factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.241: CREB, cAMP-response element-binding protein; 

Phrase: "CREB,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "cAMP-response element-binding protein"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: ";"
Processing 00000000.tx.242: GAPDH, glyceraldehyde-3-phosphate dehydrogenase; 

Phrase: "GAPDH,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "glyceraldehyde-3-phosphate dehydrogenase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.243: NMDA, N-methyl-D-aspartate; 

Phrase: "NMDA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "N-methyl-"

Phrase: "D-"

Phrase: "aspartate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.244: FAD, familial Alzheimer disease; 

Phrase: "FAD,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "familial Alzheimer disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.245: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.246: RT-PCR, reverse transcriptase-polymerase chain reaction; 

Phrase: "RT-PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "reverse transcriptase-polymerase chain reaction"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   840   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
   804   C1555029:Reverse [Idea or Concept]
   804   C2257077:transcriptase [Genetic Function]

Phrase: ";"
Processing 00000000.tx.247: z-VAD-fmk, benzyloxycarbonyl-Ala-Asp-fluoromethyl keton; 

Phrase: "z-VAD-fmk,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0383779:Z-VAD-FMK [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0077973:VAD [Therapeutic or Preventive Procedure]

Phrase: "benzyloxycarbonyl-Ala-Asp-fluoromethyl keton"

Phrase: ";"
Processing 00000000.tx.248: CRE, cAMP response element; 

Phrase: "CRE,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1511573:cAMP Response Element [Gene or Genome]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "cAMP response element"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1511573:cAMP Response Element [Gene or Genome]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: ";"
Processing 00000000.tx.249: LTP, long term potentiation; 

Phrase: "LTP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "long term potentiation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.250: DIV, days in vitro.  

Phrase: "DIV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:div. [Functional Concept]

Phrase: "days in vitro."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.251: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.252: Selkoe, D. 

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.253: J. 

Phrase: "J."
Processing 00000000.tx.254: (1999) in Alzheimer's Disease (Terry, R. D. , Katzman, R. , Bick, K. L. , and Sisodia, S. S., eds), 2nd Ed , pp. 

Phrase: "(1999"

Phrase: ")"

Phrase: "in Alzheimer's Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(Terry,"

Phrase: "R. D. ,"

Phrase: "Katzman,"

Phrase: "R. ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bick,"

Phrase: "K. L. ,"

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "S."

Phrase: ","

Phrase: "eds"

Phrase: ")"

Phrase: ","

Phrase: "2nd Ed ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "pp."
Processing 00000000.tx.255: 293-310, Lippincott Williams &Wilkins, Philadelphia 2. 

Phrase: "293-310,"

Phrase: "Lippincott Williams &Wilkins,"

Phrase: "Philadelphia 2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031525:Philadelphia [Geographic Area]
Processing 00000000.tx.256: Czech, C., Tremp, G., and Pradier, L. 

Phrase: "Czech, C., Tremp,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Pradier,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.257: (2000) Prog. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Prog."
Processing 00000000.tx.258: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.259: 60, 363-384[CrossRef][Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "60,"

Phrase: "363-384"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.260: Cai, X. 

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.261: D., Golde, T. 

Phrase: "D."

Phrase: ","

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.262: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.263: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.264: (1993) Science 259, 514-516[Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Science 259,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "514-516"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.265: Chapman, P. 

Phrase: "Chapman,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.266: F., White, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.267: L., Jones, M. 

Phrase: "L., Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443013:Jones [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.268: W., Cooper-Blacketer, D., Marshall, V. 

Phrase: "W., Cooper-Blacketer,"

Phrase: "D."

Phrase: ","

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "V."
Processing 00000000.tx.269: J., Irizarry, M., Younkin, L., Good, M. 

Phrase: "J.,"

Phrase: "Irizarry,"

Phrase: "M."

Phrase: ","

Phrase: "Younkin,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Good,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205170:Good [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.270: A., Bliss, T. 

Phrase: "A.,"

Phrase: "Bliss,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.271: V., Hyman, B. 

Phrase: "V., Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.272: T., Younkin, S. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.273: G., and Hsiao, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Hsiao,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.274: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.275: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.276: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.277: 2, 271-276[CrossRef][Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "271-276"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.278: Hsia, A. 

Phrase: "Hsia,"

Phrase: "A."
Processing 00000000.tx.279: Y., Masliah, E., McConlogue, L., Yu, G.Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. 

Phrase: "Y.,"

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.Q., Tatsuno,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Malenka,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1069595:Malenka [Eukaryote]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.280: C., Nicoll, R. 

Phrase: "C., Nicoll,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.281: A., and Mucke, L. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Mucke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.282: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.283: Natl. 

Phrase: "Natl."
Processing 00000000.tx.284: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.285: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.286: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.287: 96, 3228-3233[Abstract/Free FullText] 6. 

Phrase: "96,"

Phrase: "3228-3233"

Phrase: "[Abstract/Free FullText"

Phrase: "] 6."
Processing 00000000.tx.288: Moran, P. 

Phrase: "Moran,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945650:moran [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.289: M., Higgins, L. 

Phrase: "M."

Phrase: ","

Phrase: "Higgins,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.290: S., Cordell, B., and Moser, P. 

Phrase: "S."

Phrase: ","

Phrase: "Cordell,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Moser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.291: C. 

Phrase: "C."
Processing 00000000.tx.292: (1995) Proc. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.293: Natl. 

Phrase: "Natl."
Processing 00000000.tx.294: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.295: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.296: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.297: 92, 5341-5345[Abstract] 7. 

Phrase: "92,"

Phrase: "5341-5345"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 7."
Processing 00000000.tx.298: Calhoun, M. 

Phrase: "Calhoun,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.299: E., Wiederhold, K. 

Phrase: "E.,"

Phrase: "Wiederhold,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.300: H., Abramowski, D., Phinney, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Abramowski,"

Phrase: "D."

Phrase: ","

Phrase: "Phinney,"

Phrase: "A."
Processing 00000000.tx.301: L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., and Jucker, M. 

Phrase: "L., Probst,"

Phrase: "A.,"

Phrase: "Sturchler-Pierrat,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Staufenbiel,"

Phrase: "M."

Phrase: ","

Phrase: "Sommer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Jucker,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.302: (1998) Nature 395, 755-756[CrossRef][Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nature 395,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "755-756"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.303: Yankner, B. 

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.304: A. 

Phrase: "A."
Processing 00000000.tx.305: (1996) Neuron 16, 921-932[Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuron 16,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "921-932"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.306: Naslund, J., Haroutunian, V., Mohs, R., Davis, K. 

Phrase: "Naslund,"

Phrase: "J.,"

Phrase: "Haroutunian,"

Phrase: "V.,"

Phrase: "Mohs,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Davis,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.307: L., Davies, P., Greengard, P., and Buxbaum, J. 

Phrase: "L., Davies,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Buxbaum,"

Phrase: "J."
Processing 00000000.tx.308: D. 

Phrase: "D."
Processing 00000000.tx.309: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.310: Am. 

Phrase: "Am."
Processing 00000000.tx.311: Med. 

Phrase: "Med."
Processing 00000000.tx.312: Assoc. 

Phrase: "Assoc."
Processing 00000000.tx.313: 283, 1571-1577[Abstract/Free FullText] 10. 

Phrase: "283,"

Phrase: "1571-1577"

Phrase: "[Abstract/Free FullText"

Phrase: "] 10."
Processing 00000000.tx.314: Morris, J. 

Phrase: "Morris,"

Phrase: "J."
Processing 00000000.tx.315: C., Storandt, M., McKeel, D. 

Phrase: "C., Storandt,"

Phrase: "M."

Phrase: ","

Phrase: "McKeel,"

Phrase: "D."
Processing 00000000.tx.316: W., Jr., Rubin, E. 

Phrase: "W., Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Rubin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0252873:rubin's [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "E."
Processing 00000000.tx.317: H., Price, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.318: L., Grant, E. 

Phrase: "L., Grant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018173:Grant [Quantitative Concept]
   861   C1548284:Grant [Idea or Concept]

Phrase: "E."
Processing 00000000.tx.319: A., and Berg, L. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Berg,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.320: (1996) Neurology 46, 707-719[Abstract] 11. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neurology 46,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "707-719"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 11."
Processing 00000000.tx.321: Lue, L. 

Phrase: "Lue,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.322: F., Kuo, Y. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kuo,"

Phrase: "Y."
Processing 00000000.tx.323: M., Roher, A. 

Phrase: "M."

Phrase: ","

Phrase: "Roher,"

Phrase: "A."
Processing 00000000.tx.324: E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. 

Phrase: "E.,"

Phrase: "Brachova,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Shen,"

Phrase: "Y.,"

Phrase: "Sue"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Beach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331781:Beach [Geographic Area]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kurth,"

Phrase: "J."
Processing 00000000.tx.325: H., Rydel, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rydel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.326: E., and Rogers, J. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Rogers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "J."
Processing 00000000.tx.327: (1999) Am. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.328: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.329: 155, 853-862[Abstract/Free FullText] 12. 

Phrase: "155,"

Phrase: "853-862"

Phrase: "[Abstract/Free FullText"

Phrase: "] 12."
Processing 00000000.tx.330: Yin, J. 

Phrase: "Yin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945618:yin [Idea or Concept]

Phrase: "J."
Processing 00000000.tx.331: C., Wallach, J. 

Phrase: "C., Wallach,"

Phrase: "J."
Processing 00000000.tx.332: S., Del Vecchio, M., Wilder, E. 

Phrase: "S."

Phrase: ","

Phrase: "Del Vecchio,"

Phrase: "M."

Phrase: ","

Phrase: "Wilder,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0445392:Wild [Intellectual Product]

Phrase: "E."
Processing 00000000.tx.333: L., Zhou, H., Quinn, W. 

Phrase: "L., Zhou,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Quinn,"

Phrase: "W."
Processing 00000000.tx.334: G., and Tully, T. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Tully,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.335: (1994) Cell 79, 49-58[Medline] [OrderarticleviaInfotrieve] 13. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Cell 79,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "49-58"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 13."
Processing 00000000.tx.336: Tully, T. 

Phrase: "Tully,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.337: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.338: Natl. 

Phrase: "Natl."
Processing 00000000.tx.339: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.340: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.341: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.342: 94, 4239-4241[Free FullText] 14. 

Phrase: "94,"

Phrase: "4239-4241"

Phrase: "[Free FullText"

Phrase: "] 14."
Processing 00000000.tx.343: Abel, T., and Kandel, E. 

Phrase: "Abel,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Kandel,"

Phrase: "E."
Processing 00000000.tx.344: (1998) Brain Res. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.345: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.346: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.347: 26, 360-378[CrossRef][Medline] [OrderarticleviaInfotrieve] 15. 

Phrase: "26,"

Phrase: "360-378"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 15."
Processing 00000000.tx.348: Bourtchuladze, R., Frenguelli, B., Blendy, J., Cioffi, D., Schutz, G., and Silva, A. 

Phrase: "Bourtchuladze,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Frenguelli,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Blendy,"

Phrase: "J.,"

Phrase: "Cioffi,"

Phrase: "D."

Phrase: ","

Phrase: "Schutz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   928   C0144237:Silvan [Organic Chemical]
   907 E C0043217:Wood [Substance]
   907 E C0442548:Woods [Geographic Area]

Phrase: "A."
Processing 00000000.tx.349: J. 

Phrase: "J."
Processing 00000000.tx.350: (1994) Cell 79, 59-68[Medline] [OrderarticleviaInfotrieve] 16. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Cell 79,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "59-68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450387:68 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 16."
Processing 00000000.tx.351: Montminy, M. 

Phrase: "Montminy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.352: (1997) Annu. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.353: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.354: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.355: 66, 807-822[CrossRef][Medline] [OrderarticleviaInfotrieve] 17. 

Phrase: "66,"

Phrase: "807-822"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 17."
Processing 00000000.tx.356: Shieh, P. 

Phrase: "Shieh,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.357: B., Hu, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hu,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.358: C., Bobb, K., Timmusk, T., and Ghosh, A. 

Phrase: "C., Bobb,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Timmusk,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Ghosh,"

Phrase: "A."
Processing 00000000.tx.359: (1998) Neuron 20, 727-740[Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neuron 20,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "727-740"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.360: Tao, X., Finkbeiner, S., Arnold, D. 

Phrase: "Tao,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   944   C0041165:Troleandomycin [Antibiotic,Organic Chemical]
   916 E C0040021:taos [Disease or Syndrome]
   916 E C1551534:Taos [Population Group]

Phrase: "X.,"

Phrase: "Finkbeiner,"

Phrase: "S."

Phrase: ","

Phrase: "Arnold,"

Phrase: "D."
Processing 00000000.tx.361: B., Shaywitz, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Shaywitz,"

Phrase: "A."
Processing 00000000.tx.362: J., and Greenberg, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.363: E. 

Phrase: "E."
Processing 00000000.tx.364: (1998) Neuron 20, 709-726[Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neuron 20,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "709-726"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.365: Hu, S. 

Phrase: "Hu,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.366: C., Chrivia, J., and Ghosh, A. 

Phrase: "C., Chrivia,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Ghosh,"

Phrase: "A."
Processing 00000000.tx.367: (1999) Neuron 22, 799-808[CrossRef][Medline] [OrderarticleviaInfotrieve] 20. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neuron 22,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "799-808"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 20."
Processing 00000000.tx.368: Lu, B., and Chow, A. 

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Chow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324335:chow [Mammal]

Phrase: "A."
Processing 00000000.tx.369: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.370: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.371: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.372: 58, 76-87[CrossRef][Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "58,"

Phrase: "76-87"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.373: Black, I. 

Phrase: "Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.374: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.375: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.376: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.377: 41, 108-118[CrossRef][Medline] [OrderarticleviaInfotrieve] 22. 

Phrase: "41,"

Phrase: "108-118"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 22."
Processing 00000000.tx.378: Kesslak, J. 

Phrase: "Kesslak,"

Phrase: "J."
Processing 00000000.tx.379: P., So, V., Choi, J., Cotman, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "So,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "V.,"

Phrase: "Choi,"

Phrase: "J.,"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.380: W., and Gomez-Pinilla, F. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Gomez-Pinilla,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.381: (1998) Behav. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Behav."
Processing 00000000.tx.382: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.383: 112, 1012-1019[CrossRef][Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "112,"

Phrase: "1012-1019"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450318:1019 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.384: Phillips, H. 

Phrase: "Phillips,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.385: S., Hains, J. 

Phrase: "S."

Phrase: ","

Phrase: "Hains,"

Phrase: "J."
Processing 00000000.tx.386: M., Armanini, M., Laramee, G. 

Phrase: "M."

Phrase: ","

Phrase: "Armanini,"

Phrase: "M."

Phrase: ","

Phrase: "Laramee,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.387: R., Johnson, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Johnson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.388: A., and Winslow, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Winslow,"

Phrase: "J."
Processing 00000000.tx.389: W. 

Phrase: "W."
Processing 00000000.tx.390: (1991) Neuron 7, 695-702[Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Neuron 7,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "695-702"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.391: Ferrer, I., Marin, C., Rey, M. 

Phrase: "Ferrer,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Marin,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Rey,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.392: J., Ribalta, T., Goutan, E., Blanco, R., Tolosa, E., and Marti, E. 

Phrase: "J.,"

Phrase: "Ribalta,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Goutan,"

Phrase: "E.,"

Phrase: "Blanco,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tolosa,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Marti,"

Phrase: "E."
Processing 00000000.tx.393: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.394: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.395: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.396: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.397: 58, 729-739[Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "58,"

Phrase: "729-739"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.398: Connor, B., Young, D., Yan, Q., Faull, R. 

Phrase: "Connor,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Young,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "D."

Phrase: ","

Phrase: "Yan,"

Phrase: "Q.,"

Phrase: "Faull,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.399: L., Synek, B., and Dragunow, M. 

Phrase: "L., Synek,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Dragunow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.400: (1997) Brain Res. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.401: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.402: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.403: 49, 71-81[CrossRef][Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "49,"

Phrase: "71-81"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.404: Pike, C. 

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.405: J., Burdick, D., Walencewicz, A. 

Phrase: "J.,"

Phrase: "Burdick,"

Phrase: "D."

Phrase: ","

Phrase: "Walencewicz,"

Phrase: "A."
Processing 00000000.tx.406: J., Glabe, C. 

Phrase: "J.,"

Phrase: "Glabe,"

Phrase: "C."
Processing 00000000.tx.407: G., and Cotman, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.408: W. 

Phrase: "W."
Processing 00000000.tx.409: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.410: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.411: 13, 1676-1687[Abstract] 27. 

Phrase: "13,"

Phrase: "1676-1687"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 27."
Processing 00000000.tx.412: Ivins, K. 

Phrase: "Ivins,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.413: J., Ivins, J. 

Phrase: "J.,"

Phrase: "Ivins,"

Phrase: "J."
Processing 00000000.tx.414: K., Sharp, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sharp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1444775:Sharp [Finding]
  1000   C1539835:SHARP [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.415: P., and Cotman, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.416: W. 

Phrase: "W."
Processing 00000000.tx.417: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.418: Biol. 

Phrase: "Biol."
Processing 00000000.tx.419: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.420: 274, 2107-2112[Abstract/Free FullText] 28. 

Phrase: "274,"

Phrase: "2107-2112"

Phrase: "[Abstract/Free FullText"

Phrase: "] 28."
Processing 00000000.tx.421: Ivins, K. 

Phrase: "Ivins,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.422: J., Bui, E. 

Phrase: "J.,"

Phrase: "Bui,"

Phrase: "E."
Processing 00000000.tx.423: T., and Cotman, C. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.424: W. 

Phrase: "W."
Processing 00000000.tx.425: (1998) Neurobiol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.426: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.427: 5, 365-378[CrossRef][Medline] [OrderarticleviaInfotrieve] 29. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "365-378"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 29."
Processing 00000000.tx.428: Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., and Glabe, C. 

Phrase: "Burdick,"

Phrase: "D."

Phrase: ","

Phrase: "Soreghan,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kwon,"

Phrase: "M."

Phrase: ","

Phrase: "Kosmoski,"

Phrase: "J.,"

Phrase: "Knauer,"

Phrase: "M."

Phrase: ","

Phrase: "Henschen,"

Phrase: "A.,"

Phrase: "Yates,"

Phrase: "J.,"

Phrase: "Cotman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Glabe,"

Phrase: "C."
Processing 00000000.tx.429: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.430: Biol. 

Phrase: "Biol."
Processing 00000000.tx.431: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.432: 267, 546-554[Abstract/Free FullText] 30. 

Phrase: "267,"

Phrase: "546-554"

Phrase: "[Abstract/Free FullText"

Phrase: "] 30."
Processing 00000000.tx.433: Cribbs, D. 

Phrase: "Cribbs,"

Phrase: "D."
Processing 00000000.tx.434: H., Pike, C. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.435: J., Weinstein, S. 

Phrase: "J.,"

Phrase: "Weinstein,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.436: L., Velazquez, P., and Cotman, C. 

Phrase: "L., Velazquez,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.437: W. 

Phrase: "W."
Processing 00000000.tx.438: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.439: Biol. 

Phrase: "Biol."
Processing 00000000.tx.440: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.441: 272, 7431-7436[Abstract/Free FullText] 31. 

Phrase: "272,"

Phrase: "7431-7436"

Phrase: "[Abstract/Free FullText"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.442: Oda, T., Wals, P., Osterburg, H. 

Phrase: "Oda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057642:ODA [Organic Chemical,Pharmacologic Substance]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wals,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Osterburg,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.443: H., Johnson, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Johnson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.444: A., Pasinetti, G. 

Phrase: "A.,"

Phrase: "Pasinetti,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.445: M., Morgan, T. 

Phrase: "M."

Phrase: ","

Phrase: "Morgan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.446: E., Rozovsky, I., Stine, W. 

Phrase: "E.,"

Phrase: "Rozovsky,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Stine,"

Phrase: "W."
Processing 00000000.tx.447: B., Snyder, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Snyder,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.448: W., Holzman, T. 

Phrase: "W., Holzman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.449: F., Krafft, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.450: A., and Finch, C. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "C."
Processing 00000000.tx.451: E. 

Phrase: "E."
Processing 00000000.tx.452: (1995) Exp. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.453: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.454: 136, 22-31[CrossRef][Medline] [OrderarticleviaInfotrieve] 32. 

Phrase: "136,"

Phrase: "22-31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 32."
Processing 00000000.tx.455: Lambert, M. 

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.456: P., Barlow, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Barlow,"

Phrase: "A."
Processing 00000000.tx.457: K., Chromy, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chromy,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.458: A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. 

Phrase: "A.,"

Phrase: "Edwards,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Freed,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0332296:free [Functional Concept]
   966   C1880497:Free [Qualitative Concept]
   966   C1996904:Free [Qualitative Concept]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Liosatos,"

Phrase: "M."

Phrase: ","

Phrase: "Morgan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.459: E., Rozovsky, I., Trommer, B., Viola, K. 

Phrase: "E.,"

Phrase: "Rozovsky,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Trommer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Viola,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0330463:Viola [Plant]
  1000   C2673181:Viola [Eukaryote]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.460: L., Wals, P., Zhang, C., Finch, C. 

Phrase: "L., Wals,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Zhang,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "C."
Processing 00000000.tx.461: E., Krafft, G. 

Phrase: "E.,"

Phrase: "Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.462: A., and Klein, W. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Klein,"

Phrase: "W."
Processing 00000000.tx.463: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.464: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.465: Natl. 

Phrase: "Natl."
Processing 00000000.tx.466: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.467: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.468: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.469: 95, 6448-6453[Abstract/Free FullText] 33. 

Phrase: "95,"

Phrase: "6448-6453"

Phrase: "[Abstract/Free FullText"

Phrase: "] 33."
Processing 00000000.tx.470: Myers, S. 

Phrase: "Myers,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.471: J., Peters, J., Huang, Y., Comer, M. 

Phrase: "J.,"

Phrase: "Peters,"

Phrase: "J.,"

Phrase: "Huang,"

Phrase: "Y.,"

Phrase: "Comer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.472: B., Barthel, F., and Dingledine, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Barthel,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Dingledine,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.473: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.474: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.475: 18, 6723-6739[Abstract/Free FullText] 34. 

Phrase: "18,"

Phrase: "6723-6739"

Phrase: "[Abstract/Free FullText"

Phrase: "] 34."
Processing 00000000.tx.476: Cotman, C. 

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.477: W., Ivins, K. 

Phrase: "W., Ivins,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.478: J., and Anderson, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Anderson,"

Phrase: "A."
Processing 00000000.tx.479: J. 

Phrase: "J."
Processing 00000000.tx.480: (1999) in Alzheimer's Disease (Terry, R. D. , Katzman, R. , Bick, K. L. , and Sisodia, S. S., eds), 2nd Ed , pp. 

Phrase: "(1999"

Phrase: ")"

Phrase: "in Alzheimer's Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(Terry,"

Phrase: "R. D. ,"

Phrase: "Katzman,"

Phrase: "R. ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bick,"

Phrase: "K. L. ,"

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "S."

Phrase: ","

Phrase: "eds"

Phrase: ")"

Phrase: ","

Phrase: "2nd Ed ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "pp."
Processing 00000000.tx.481: 347-358, Lippincott Williams &Wilkins, Philadelphia 35. 

Phrase: "347-358,"

Phrase: "Lippincott Williams &Wilkins,"

Phrase: "Philadelphia 35."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031525:Philadelphia [Geographic Area]
Processing 00000000.tx.482: Malenka, R. 

Phrase: "Malenka,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1069595:Malenka [Eukaryote]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.483: C., and Nicoll, R. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Nicoll,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.484: A. 

Phrase: "A."
Processing 00000000.tx.485: (1993) Trends Neurosci. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.486: 16, 521-527[CrossRef][Medline] [OrderarticleviaInfotrieve] 36. 

Phrase: "16,"

Phrase: "521-527"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 36."
Processing 00000000.tx.487: Bliss, T. 

Phrase: "Bliss,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.488: V., and Collingridge, G. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Collingridge,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.489: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.490: (1993) Nature 361, 31-39[CrossRef][Medline] [OrderarticleviaInfotrieve] 37. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature 361,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "31-39"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 37."
Processing 00000000.tx.491: Ivins, K. 

Phrase: "Ivins,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.492: J., Thornton, P. 

Phrase: "J.,"

Phrase: "Thornton,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.493: L., Rohn, T. 

Phrase: "L., Rohn,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.494: T., and Cotman, C. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.495: W. 

Phrase: "W."
Processing 00000000.tx.496: (1999) Neurobiol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.497: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.498: 6, 440-449[CrossRef][Medline] [OrderarticleviaInfotrieve] 38. 

Phrase: "6,"

Phrase: "440-449"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 38."
Processing 00000000.tx.499: Troy, C. 

Phrase: "Troy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420811:TROY [Gene or Genome]
  1000   C1883402:Troy [Quantitative Concept]

Phrase: "C."
Processing 00000000.tx.500: M., Rabacchi, S. 

Phrase: "M."

Phrase: ","

Phrase: "Rabacchi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.501: A., Friedman, W. 

Phrase: "A.,"

Phrase: "Friedman,"

Phrase: "W."
Processing 00000000.tx.502: J., Frappier, T. 

Phrase: "J.,"

Phrase: "Frappier,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.503: F., Brown, K., and Shelanski, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Shelanski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.504: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.505: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.506: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.507: 20, 1386-1392[Abstract/Free FullText] 39. 

Phrase: "20,"

Phrase: "1386-1392"

Phrase: "[Abstract/Free FullText"

Phrase: "] 39."
Processing 00000000.tx.508: Kluck, R. 

Phrase: "Kluck,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.509: M., Bossy-Wetzel, E., Green, D. 

Phrase: "M."

Phrase: ","

Phrase: "Bossy-Wetzel,"

Phrase: "E.,"

Phrase: "Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "D."
Processing 00000000.tx.510: R., and Newmeyer, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Newmeyer,"

Phrase: "D."
Processing 00000000.tx.511: D. 

Phrase: "D."
Processing 00000000.tx.512: (1997) Science 275, 1132-1136[Abstract/Free FullText] 40. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 275,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1132-1136"

Phrase: "[Abstract/Free FullText"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.513: Fu, W., Begley, J. 

Phrase: "Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "W.,"

Phrase: "Begley,"

Phrase: "J."
Processing 00000000.tx.514: G., Killen, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Killen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.515: W., and Mattson, M. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.516: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.517: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.518: Biol. 

Phrase: "Biol."
Processing 00000000.tx.519: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.520: 274, 7264-7271[Abstract/Free FullText] 41. 

Phrase: "274,"

Phrase: "7264-7271"

Phrase: "[Abstract/Free FullText"

Phrase: "] 41."
Processing 00000000.tx.521: Namgung, U., and Xia, Z. 

Phrase: "Namgung,"

Phrase: "U.,"

Phrase: "and"

Phrase: "Xia,"

Phrase: "Z."
Processing 00000000.tx.522: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.523: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.524: 20, 6442-6451[Abstract/Free FullText] 42. 

Phrase: "20,"

Phrase: "6442-6451"

Phrase: "[Abstract/Free FullText"

Phrase: "] 42."
Processing 00000000.tx.525: Timmusk, T., Palm, K., Metsis, M., Reintam, T., Paalme, V., Saarma, M., and Persson, H. 

Phrase: "Timmusk,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Palm,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0230373:Palm [Body Location or Region]
  1000   C0817662:Palm [Body Location or Region]
  1000   C1418262:PALM [Gene or Genome]
   944 E C0230374:Thenar [Body Location or Region]
   916 E C0682477:palms [Plant]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Metsis,"

Phrase: "M."

Phrase: ","

Phrase: "Reintam,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Paalme,"

Phrase: "V.,"

Phrase: "Saarma,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Persson,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.526: (1993) Neuron 10, 475-489[Medline] [OrderarticleviaInfotrieve] 43. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Neuron 10,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "475-489"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 43."
Processing 00000000.tx.527: Hsiao, K. 

Phrase: "Hsiao,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.528: (1998) Exp. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.529: Gerontol. 

Phrase: "Gerontol."
Processing 00000000.tx.530: 33, 883-889[CrossRef][Medline] [OrderarticleviaInfotrieve] 44. 

Phrase: "33,"

Phrase: "883-889"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 44."
Processing 00000000.tx.531: Hartley, D. 

Phrase: "Hartley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324525:Hartley [Mammal]

Phrase: "D."
Processing 00000000.tx.532: M., Walsh, D. 

Phrase: "M."

Phrase: ","

Phrase: "Walsh,"

Phrase: "D."
Processing 00000000.tx.533: M., Ye, C. 

Phrase: "M."

Phrase: ","

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "C."
Processing 00000000.tx.534: P., Diehl, T., Vasquez, S., Vassilev, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Diehl,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Vasquez,"

Phrase: "S."

Phrase: ","

Phrase: "Vassilev,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.535: M., Teplow, D. 

Phrase: "M."

Phrase: ","

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.536: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.537: J. 

Phrase: "J."
Processing 00000000.tx.538: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.539: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.540: 19, 8876-8884[Abstract/Free FullText] 45. 

Phrase: "19,"

Phrase: "8876-8884"

Phrase: "[Abstract/Free FullText"

Phrase: "] 45."
Processing 00000000.tx.541: Yamamoto-Sasaki, M., Ozawa, H., Saito, T., Rosler, M., and Riederer, P. 

Phrase: "Yamamoto-Sasaki,"

Phrase: "M."

Phrase: ","

Phrase: "Ozawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saito,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Rosler,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Riederer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.542: (1999) Brain Res. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.543: 824, 300-303[CrossRef][Medline] [OrderarticleviaInfotrieve] 46. 

Phrase: "824,"

Phrase: "300-303"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 46."
Processing 00000000.tx.544: Sato, N., Kamino, K., Tateishi, K., Satoh, T., Nishiwaki, Y., Yoshiiwa, A., Miki, T., and Ogihara, T. 

Phrase: "Sato,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kamino,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tateishi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Satoh,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nishiwaki,"

Phrase: "Y.,"

Phrase: "Yoshiiwa,"

Phrase: "A.,"

Phrase: "Miki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2681565:MIKI [Gene or Genome]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Ogihara,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.545: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.546: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.547: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.548: Commun. 

Phrase: "Commun."
Processing 00000000.tx.549: 232, 637-642[CrossRef][Medline] [OrderarticleviaInfotrieve] 47. 

Phrase: "232,"

Phrase: "637-642"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 47."
Processing 00000000.tx.550: McDonald, D. 

Phrase: "McDonald,"

Phrase: "D."
Processing 00000000.tx.551: R., Bamberger, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bamberger,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.552: E., Combs, C. 

Phrase: "E.,"

Phrase: "Combs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376161:Combs [Body Part, Organ, or Organ Component]

Phrase: "C."
Processing 00000000.tx.553: K., and Landreth, G. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Landreth,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.554: E. 

Phrase: "E."
Processing 00000000.tx.555: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.556: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.557: 18, 4451-4460[Abstract/Free FullText] 48. 

Phrase: "18,"

Phrase: "4451-4460"

Phrase: "[Abstract/Free FullText"

Phrase: "] 48."
Processing 00000000.tx.558: Ikezu, T., Okamoto, T., Komatsuzaki, K., Matsui, T., Martyn, J. 

Phrase: "Ikezu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Komatsuzaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Matsui,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Martyn,"

Phrase: "J."
Processing 00000000.tx.559: A., and Nishimoto, I. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Nishimoto,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.560: (1996) EMBO J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.561: 15, 2468-2475[Abstract] Copyright  2001 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "15,"

Phrase: "2468-2475"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Copyright  2001 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

